RP0738 personal page - To The Moon

RP0738

No personal profile

0Follow

1Followers

0Topic

0Badge

2022-07-07

ok

@TradingLounge:Australian Stock Market Elliott Wave Analysis Trading Levels ASX 200 Index (XJO), Forex AUDUSD, Commonwealth Bank CBA, BHP Group (BHP), Rio Tinto (RIO), Fortescue Metals Group (FMG), Woodside (WDS) Santos (STO), Newcrest Mining NCM, VanEck Gold Miners ETF GDX, Technical Analysis Trading StrategiesASX200 Market Summary Elliott Wave ASX200: Wave (4) completed and the next leg lower is underway...as one's and two'sASX200 Trading Strategy: In this video we are looking for short trade setups in the ASX200 as Wave v of (c) of ii)Video Chapters 00:00 ASX200 (XJO) 07:10 Commonwealth Bank CBA 08:17 Iron Ore BHP RIO FMG 13:39 Natural Gas, STO, WDS 20:12 US Spot Gold GDX NCM 26:32 Thanks for watching! Analyst Peter Mathers TradingLounge™ Australian Financial Services Licence - AFSL 317817@Daily

2022-06-30

ok

@TradingLounge:NASDAQ, AMZN, AAPL, NVDA, TSLA, GOOGL, BRK, SQ, META, MSFT, BAC, JPM. Elliott Wave Technical Analysis Stock Market TradingElliott Wave Technical Analysis Stocks are in the later stages of the move down (5) of C) of II. That said we are currently in a bear market rally. Covering Tesla TSLA, Amazon AMZN, Nvidia (NVDA), Apple AAPL, Microsoft MSFT, Berkshire Hathaway (BRK/B),Block, Inc (SQ), Facebook FB, Meta Platforms, Alphabet GOOGL. XFL Finance Sector ETF, JPMorgan JPM & Bank of America BAC.Stock Market Summary: Elliott Wave move up as the correctie rally is completed and we are now working then next leg lower.Stock Trading strategies: We are now preparing for short trades on the next corrective rally as the Wave ii)SPECIAL DEAL buy 1 month Get 3 months : tradinglounge.comVideo Chapters

2022-03-07

Thx

姜还是老的辣！油价暴涨，巴菲特大手笔买入石油公司

2022-01-18

Thx

5 Stocks To Watch For January 18, 2022

2022-01-13

Wow

2022 Market Prediction: Coca-Cola Outperforms PepsiCo

2022-01-09

Thx

Sorry, the original content has been removed

2022-01-08

Fingers crossed

3 COVID Stocks That Will Make Billions in 2022

2022-01-05

Thx

Sorry, the original content has been removed

2022-01-01

Thx

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3571797176941843","uuid":"3571797176941843","gmtCreate":1608728138935,"gmtModify":1608728138935,"name":"RP0738","pinyin":"rp0738","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":0,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.09.20","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.83%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.61%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9079918287,"gmtCreate":1657145782749,"gmtModify":1676535955688,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9079918287","repostId":"9070284014","repostType":1,"repost":{"id":9070284014,"gmtCreate":1657067477439,"gmtModify":1676535942615,"author":{"id":"4119072940563712","authorId":"4119072940563712","name":"TradingLounge","avatar":"https://community-static.tradeup.com/news/e3847b140dde3f0115931dbd158233e5","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4119072940563712","authorIdStr":"4119072940563712"},"themes":[],"title":"ASX200, CBA, Iron Ore, BHP, FMG, RIO, GOLD, NCM, Natural Gas, Crude Oil AUDUSD DXY Elliott Wave","htmlText":"\n \n \n  Australian Stock Market Elliott Wave Analysis Trading Levels ASX 200 Index (XJO), Forex AUDUSD, Commonwealth Bank CBA, BHP Group (BHP), Rio Tinto (RIO), Fortescue Metals Group (FMG), Woodside (WDS) Santos (STO), Newcrest Mining NCM, VanEck Gold Miners ETF GDX, Technical Analysis Trading StrategiesASX200 Market Summary Elliott Wave ASX200: Wave (4) completed and the next leg lower is underway...as one's and two'sASX200 Trading Strategy: In this video we are looking for short trade setups in the ASX200 as Wave v of (c) of ii)Video Chapters 00:00 ASX200 (XJO) 07:10 Commonwealth Bank CBA 08:17 Iron Ore BHP RIO FMG 13:39 Natural Gas, STO, WDS 20:12 US Spot Gold GDX NCM 26:32 Thanks for watching! &nbsp;Analyst Peter Mathers TradingLounge™ Australian Financial Services Licence - AFSL 317817@Daily\n \n","listText":"Australian Stock Market Elliott Wave Analysis Trading Levels ASX 200 Index (XJO), Forex AUDUSD, Commonwealth Bank CBA, BHP Group (BHP), Rio Tinto (RIO), Fortescue Metals Group (FMG), Woodside (WDS) Santos (STO), Newcrest Mining NCM, VanEck Gold Miners ETF GDX, Technical Analysis Trading StrategiesASX200 Market Summary Elliott Wave ASX200: Wave (4) completed and the next leg lower is underway...as one's and two'sASX200 Trading Strategy: In this video we are looking for short trade setups in the ASX200 as Wave v of (c) of ii)Video Chapters 00:00 ASX200 (XJO) 07:10 Commonwealth Bank CBA 08:17 Iron Ore BHP RIO FMG 13:39 Natural Gas, STO, WDS 20:12 US Spot Gold GDX NCM 26:32 Thanks for watching! &nbsp;Analyst Peter Mathers TradingLounge™ Australian Financial Services Licence - AFSL 317817@Daily","text":"Australian Stock Market Elliott Wave Analysis Trading Levels ASX 200 Index (XJO), Forex AUDUSD, Commonwealth Bank CBA, BHP Group (BHP), Rio Tinto (RIO), Fortescue Metals Group (FMG), Woodside (WDS) Santos (STO), Newcrest Mining NCM, VanEck Gold Miners ETF GDX, Technical Analysis Trading StrategiesASX200 Market Summary Elliott Wave ASX200: Wave (4) completed and the next leg lower is underway...as one's and two'sASX200 Trading Strategy: In this video we are looking for short trade setups in the ASX200 as Wave v of (c) of ii)Video Chapters 00:00 ASX200 (XJO) 07:10 Commonwealth Bank CBA 08:17 Iron Ore BHP RIO FMG 13:39 Natural Gas, STO, WDS 20:12 US Spot Gold GDX NCM 26:32 Thanks for watching! Analyst Peter Mathers TradingLounge™ Australian Financial Services Licence - AFSL 317817@Daily","images":[],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9070284014","isVote":1,"tweetType":2,"object":{"id":"098d58bf19cc46cc9db1d2bd86ef020e","tweetId":"9070284014","videoUrl":"https://1254107296.vod2.myqcloud.com/3e467bc5vodtranssgp1254107296/09e5ac4c387702302931753074/v.f30.mp4","poster":"https://community-static.tradeup.com/news/034ed2fa8717605bb091dbd1c5ebb866"},"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":427,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9042771717,"gmtCreate":1656543500139,"gmtModify":1676535847504,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9042771717","repostId":"9042340268","repostType":1,"repost":{"id":9042340268,"gmtCreate":1656450103554,"gmtModify":1676535828435,"author":{"id":"4119072940563712","authorId":"4119072940563712","name":"TradingLounge","avatar":"https://community-static.tradeup.com/news/e3847b140dde3f0115931dbd158233e5","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4119072940563712","authorIdStr":"4119072940563712"},"themes":[],"title":"NASDAQ, AMZN, AAPL, NVDA, TSLA, GOOGL, BRK.B,SQ,META,MSFT,BAC,JPM. Elliott Wave Stock Market Trading","htmlText":"\n \n \n  NASDAQ, AMZN, AAPL, NVDA, TSLA, GOOGL, BRK, SQ, META, MSFT, BAC, JPM. Elliott Wave Technical Analysis Stock Market TradingElliott Wave Technical Analysis Stocks are in the later stages of the move down (5) of C) of II. That said we are currently in a bear market rally. Covering Tesla TSLA, Amazon AMZN, Nvidia (NVDA), Apple AAPL, Microsoft MSFT, Berkshire Hathaway (BRK/B),Block, Inc (SQ), Facebook FB, Meta Platforms, Alphabet GOOGL. XFL Finance Sector ETF, JPMorgan JPM &amp; Bank of America BAC.Stock Market Summary: Elliott Wave move up as the correctie rally is completed and we are now working then next leg lower.Stock Trading strategies: We are now preparing for short trades on the next corrective rally as the Wave ii)SPECIAL DEAL buy 1 month Get 3 months : tradinglounge.comVideo Chapters\n \n","listText":"NASDAQ, AMZN, AAPL, NVDA, TSLA, GOOGL, BRK, SQ, META, MSFT, BAC, JPM. Elliott Wave Technical Analysis Stock Market TradingElliott Wave Technical Analysis Stocks are in the later stages of the move down (5) of C) of II. That said we are currently in a bear market rally. Covering Tesla TSLA, Amazon AMZN, Nvidia (NVDA), Apple AAPL, Microsoft MSFT, Berkshire Hathaway (BRK/B),Block, Inc (SQ), Facebook FB, Meta Platforms, Alphabet GOOGL. XFL Finance Sector ETF, JPMorgan JPM &amp; Bank of America BAC.Stock Market Summary: Elliott Wave move up as the correctie rally is completed and we are now working then next leg lower.Stock Trading strategies: We are now preparing for short trades on the next corrective rally as the Wave ii)SPECIAL DEAL buy 1 month Get 3 months : tradinglounge.comVideo Chapters","text":"NASDAQ, AMZN, AAPL, NVDA, TSLA, GOOGL, BRK, SQ, META, MSFT, BAC, JPM. Elliott Wave Technical Analysis Stock Market TradingElliott Wave Technical Analysis Stocks are in the later stages of the move down (5) of C) of II. That said we are currently in a bear market rally. Covering Tesla TSLA, Amazon AMZN, Nvidia (NVDA), Apple AAPL, Microsoft MSFT, Berkshire Hathaway (BRK/B),Block, Inc (SQ), Facebook FB, Meta Platforms, Alphabet GOOGL. XFL Finance Sector ETF, JPMorgan JPM & Bank of America BAC.Stock Market Summary: Elliott Wave move up as the correctie rally is completed and we are now working then next leg lower.Stock Trading strategies: We are now preparing for short trades on the next corrective rally as the Wave ii)SPECIAL DEAL buy 1 month Get 3 months : tradinglounge.comVideo Chapters","images":[{"img":"https://community-static.tradeup.com/news/9430a9b23ab49bd3c719810b1eab9493","width":"0","height":"0"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9042340268","isVote":1,"tweetType":2,"object":{"id":"85a868088e76492d9890af2d2fd36e98","tweetId":"9042340268","videoUrl":"https://1254107296.vod2.myqcloud.com/8e2bc32evodtranshk1254107296/6bddd4a1387702302338810122/v.f30.mp4","poster":"https://community-static.tradeup.com/news/9430a9b23ab49bd3c719810b1eab9493"},"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":438,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9031523658,"gmtCreate":1646618158403,"gmtModify":1676534143995,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"Thx","listText":"Thx","text":"Thx","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031523658","repostId":"2217949664","repostType":2,"repost":{"id":"2217949664","kind":"highlight","pubTimestamp":1646610950,"share":"https://ttm.financial/m/news/2217949664?lang=&edition=fundamental","pubTime":"2022-03-07 07:55","market":"us","language":"zh","title":"姜还是老的辣！油价暴涨，巴菲特大手笔买入石油公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2217949664","media":"华尔街见闻","summary":"被巴菲特“重拾”的石油股，本周大涨45%。","content":"<html><head></head><body><p>全球油价大涨，巴菲特又重拾了两年前清仓的石油股。</p><p>本周五，美国证券交易委员会的一份新文件显示，巴菲特旗下的<a href=\"https://laohu8.com/S/BRK\">伯克希尔</a>哈撒韦公司增持了<a href=\"https://laohu8.com/S/OXY\">西方石油</a>公司股份，目前持有股份达到1.13亿股，价值53亿美元。</p><p>在伯克希尔哈撒韦持有的1.13亿股中，仅有2900多万股为普通股，剩余8300多万股以认股权证形式存在，执行价格为59.624美元。<img src=\"https://static.tigerbbs.com/9bd160e1dca73e9d48ef2b7d89e9e95a\" tg-width=\"2712\" tg-height=\"1368\" referrerpolicy=\"no-referrer\"/>本周五，西方石油公司上涨18%，本周上涨45%，收盘价为56.15美元。<img src=\"https://static.tigerbbs.com/e1a52f55237b86052b29cf203b00024c\" tg-width=\"1301\" tg-height=\"1065\" referrerpolicy=\"no-referrer\"/><b>随着俄乌争端的爆发，全球油价一路走高，目前已飙升至115美元以上</b>，巴菲特也因此觉察这个机会，大举买入石油公司股票。</p><p>目前其投资组合中超过6100万股股票是在周三，周四和周五购买的，价格从47.07美元到56.45美元不等。<b>但根据伯克希尔哈撒韦最新的13F文件，截至2021年12月31日，该公司没有持有西方石油公司的股票。</b></p><p>目前尚不知晓剩余的股票是在何时买入，因为伯克希尔哈撒韦持有西方石油公司的所有权尚不满10%，监管不要求披露。</p><p>不过，尽管这些认股权证没有被行使，但出于向证交会提交申请的目的，这些认股权证必须被计算在内，<b>从技术上讲，伯克希尔哈撒韦持有的股份将超过17%。</b></p><p>伯克希尔哈撒韦获得的这些权证来自于2019年向西方石油公司提供的100亿美元贷款，帮助其以380亿美元收购阿纳达科公司。</p><p>这笔贷款以伯克希尔哈撒韦购买优先股的形式发放，要求西方石油公司每年支付8%的股息。也就是每个季度2亿美元。</p><p>当时巴菲特对CNBC表示，他是在押注油价将长期上涨。</p><p>不过后来，巴菲特押注的油价在2020年初因新冠疫情爆发而表现不佳。在那年的股东大会上，巴菲特说：</p><blockquote>“如果你是西方石油股东或任何一家石油生产公司的股东，在油价走向方面你和我都犯了一个错误。”</blockquote><p>为了节省现金，西方石油公司以股票的形式向伯克希尔哈撒韦支付了第一和第二季度的贷款，后者分别获得了1730万股和1160万股股票。</p><p><b>但截至2020年6月30日和9月30日，伯克希尔哈撒韦的13F文件中根本没有列出任何西方石油公司的股票，</b>这表明，在石油市场的暴跌中，该公司出售了所购买的1900万股股票，以及作为股息收到的近2900万股股票。</p><p>而现在，随着油价再次走强，巴菲特的投资组合中又出现了石油公司的名字。</p></body></html>","source":"wallstreetcn_api","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>姜还是老的辣！油价暴涨，巴菲特大手笔买入石油公司</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n姜还是老的辣！油价暴涨，巴菲特大手笔买入石油公司\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-07 07:55 北京时间&nbsp;&nbsp;&nbsp;<a href=https://wallstreetcn.com/articles/3653483><strong>华尔街见闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>全球油价大涨，巴菲特又重拾了两年前清仓的石油股。本周五，美国证券交易委员会的一份新文件显示，巴菲特旗下的伯克希尔哈撒韦公司增持了西方石油公司股份，目前持有股份达到1.13亿股，价值53亿美元。在伯克希尔哈撒韦持有的1.13亿股中，仅有2900多万股为普通股，剩余8300多万股以认股权证形式存在，执行价格为59.624美元。本周五，西方石油公司上涨18%，本周上涨45%，收盘价为56.15美元。随着...</p>\n\n<a href=\"https://wallstreetcn.com/articles/3653483\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f3ecc14db02762fcb82cdbb76e654301","relate_stocks":{"BK4176":"多领域控股","BK4534":"瑞士信贷持仓","BRK.B":"伯克希尔B","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BRK.A":"伯克希尔"},"source_url":"https://wallstreetcn.com/articles/3653483","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2217949664","content_text":"全球油价大涨，巴菲特又重拾了两年前清仓的石油股。本周五，美国证券交易委员会的一份新文件显示，巴菲特旗下的伯克希尔哈撒韦公司增持了西方石油公司股份，目前持有股份达到1.13亿股，价值53亿美元。在伯克希尔哈撒韦持有的1.13亿股中，仅有2900多万股为普通股，剩余8300多万股以认股权证形式存在，执行价格为59.624美元。本周五，西方石油公司上涨18%，本周上涨45%，收盘价为56.15美元。随着俄乌争端的爆发，全球油价一路走高，目前已飙升至115美元以上，巴菲特也因此觉察这个机会，大举买入石油公司股票。目前其投资组合中超过6100万股股票是在周三，周四和周五购买的，价格从47.07美元到56.45美元不等。但根据伯克希尔哈撒韦最新的13F文件，截至2021年12月31日，该公司没有持有西方石油公司的股票。目前尚不知晓剩余的股票是在何时买入，因为伯克希尔哈撒韦持有西方石油公司的所有权尚不满10%，监管不要求披露。不过，尽管这些认股权证没有被行使，但出于向证交会提交申请的目的，这些认股权证必须被计算在内，从技术上讲，伯克希尔哈撒韦持有的股份将超过17%。伯克希尔哈撒韦获得的这些权证来自于2019年向西方石油公司提供的100亿美元贷款，帮助其以380亿美元收购阿纳达科公司。这笔贷款以伯克希尔哈撒韦购买优先股的形式发放，要求西方石油公司每年支付8%的股息。也就是每个季度2亿美元。当时巴菲特对CNBC表示，他是在押注油价将长期上涨。不过后来，巴菲特押注的油价在2020年初因新冠疫情爆发而表现不佳。在那年的股东大会上，巴菲特说：“如果你是西方石油股东或任何一家石油生产公司的股东，在油价走向方面你和我都犯了一个错误。”为了节省现金，西方石油公司以股票的形式向伯克希尔哈撒韦支付了第一和第二季度的贷款，后者分别获得了1730万股和1160万股股票。但截至2020年6月30日和9月30日，伯克希尔哈撒韦的13F文件中根本没有列出任何西方石油公司的股票，这表明，在石油市场的暴跌中，该公司出售了所购买的1900万股股票，以及作为股息收到的近2900万股股票。而现在，随着油价再次走强，巴菲特的投资组合中又出现了石油公司的名字。","news_type":1},"isVote":1,"tweetType":1,"viewCount":562,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9004334051,"gmtCreate":1642503694600,"gmtModify":1676533716109,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"Thx","listText":"Thx","text":"Thx","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004334051","repostId":"1167491225","repostType":4,"repost":{"id":"1167491225","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1642500977,"share":"https://ttm.financial/m/news/1167491225?lang=&edition=fundamental","pubTime":"2022-01-18 18:16","market":"us","language":"en","title":"5 Stocks To Watch For January 18, 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1167491225","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:Wall Street expects The Goldman Sachs Grou","content":"<html><head></head><body><p>Some of the stocks that may grab investor focus today are:</p><ul><li>Wall Street expects <b>The Goldman Sachs Group, Inc.</b> to report quarterly earnings at $11.73 per share on revenue of $12.01 billion before the opening bell. Goldman Sachs shares gained 0.1% to $381.19 in pre-market trading.</li><li><b>Plus Therapeutics</b> reported an offering of up to $5 million. Plus Therapeutics shares fell 1% to $1.02 in the after-hours trading session.</li><li>Analysts are expecting <b>The PNC Financial Services Group, Inc.</b> to have earned $3.22 per share on revenue of $5.14 billion for the latest quarter. The bank will release earnings before the markets open. PNC Financial shares gained 0.1% to $222.49 in after-hours trading.</li></ul><ul><li><b>Schmitt Industries, Inc.</b> reported net income of $0.57 per share for the three months ended November 30, 2021, versus a year-ago net loss of $0.63, per share. Consolidated revenues jumped 45.9% year-over-year to $2.961 million for the quarter. Schmitt Industries shares gained 3.9% to $5.35 in the after-hours trading session.</li><li>Analysts expect <b>J.B. Hunt Transport Services, Inc.</b> to report quarterly earnings at $2.01 per share on revenue of $3.28 billion after the closing bell. J.B. Hunt Transport shares rose 0.2% to $202.51 in after-hours trading.</li></ul></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For January 18, 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For January 18, 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-01-18 18:16</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Some of the stocks that may grab investor focus today are:</p><ul><li>Wall Street expects <b>The Goldman Sachs Group, Inc.</b> to report quarterly earnings at $11.73 per share on revenue of $12.01 billion before the opening bell. Goldman Sachs shares gained 0.1% to $381.19 in pre-market trading.</li><li><b>Plus Therapeutics</b> reported an offering of up to $5 million. Plus Therapeutics shares fell 1% to $1.02 in the after-hours trading session.</li><li>Analysts are expecting <b>The PNC Financial Services Group, Inc.</b> to have earned $3.22 per share on revenue of $5.14 billion for the latest quarter. The bank will release earnings before the markets open. PNC Financial shares gained 0.1% to $222.49 in after-hours trading.</li></ul><ul><li><b>Schmitt Industries, Inc.</b> reported net income of $0.57 per share for the three months ended November 30, 2021, versus a year-ago net loss of $0.63, per share. Consolidated revenues jumped 45.9% year-over-year to $2.961 million for the quarter. Schmitt Industries shares gained 3.9% to $5.35 in the after-hours trading session.</li><li>Analysts expect <b>J.B. Hunt Transport Services, Inc.</b> to report quarterly earnings at $2.01 per share on revenue of $3.28 billion after the closing bell. J.B. Hunt Transport shares rose 0.2% to $202.51 in after-hours trading.</li></ul></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SMIT":"施密特工业","GS":"高盛","PNC":"PNC金融","PSTV":"Plus Therapeutics, Inc.","JBHT":"JB Hunt运输服务"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167491225","content_text":"Some of the stocks that may grab investor focus today are:Wall Street expects The Goldman Sachs Group, Inc. to report quarterly earnings at $11.73 per share on revenue of $12.01 billion before the opening bell. Goldman Sachs shares gained 0.1% to $381.19 in pre-market trading.Plus Therapeutics reported an offering of up to $5 million. Plus Therapeutics shares fell 1% to $1.02 in the after-hours trading session.Analysts are expecting The PNC Financial Services Group, Inc. to have earned $3.22 per share on revenue of $5.14 billion for the latest quarter. The bank will release earnings before the markets open. PNC Financial shares gained 0.1% to $222.49 in after-hours trading.Schmitt Industries, Inc. reported net income of $0.57 per share for the three months ended November 30, 2021, versus a year-ago net loss of $0.63, per share. Consolidated revenues jumped 45.9% year-over-year to $2.961 million for the quarter. Schmitt Industries shares gained 3.9% to $5.35 in the after-hours trading session.Analysts expect J.B. Hunt Transport Services, Inc. to report quarterly earnings at $2.01 per share on revenue of $3.28 billion after the closing bell. J.B. Hunt Transport shares rose 0.2% to $202.51 in after-hours trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":410,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002553232,"gmtCreate":1642047446311,"gmtModify":1676533675805,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002553232","repostId":"2202730280","repostType":4,"repost":{"id":"2202730280","kind":"highlight","pubTimestamp":1642043568,"share":"https://ttm.financial/m/news/2202730280?lang=&edition=fundamental","pubTime":"2022-01-13 11:12","market":"us","language":"en","title":"2022 Market Prediction: Coca-Cola Outperforms PepsiCo","url":"https://stock-news.laohu8.com/highlight/detail?id=2202730280","media":"Motley Fool","summary":"Momentum in economic reopenings could be the catalyst that turns the tide in Coca-Cola's favor.","content":"<html><head></head><body><p>International consumer packaged-goods giants <b>Coca-Cola</b> (NYSE:KO) and <b>PepsiCo</b> (NASDAQ:PEP) have competed for decades. The two are similar regarding the beverages they sell worldwide. The <a href=\"https://laohu8.com/S/AONE.U\">one</a> significant difference is that PepsiCo has a robust snack segment.</p><p>In 2021, PepsiCo&#39;s stock returned 17%, handily outperforming Coca-Cola&#39;s return of 8%. That being said, I&#39;m going to go out on a limb and predict that Coca-Cola will turn the tables in 2022.</p><h2>Stay-at-home trends were good for PepsiCo&#39;s business</h2><p>The effects of the pandemic were helpful to PepsiCo&#39;s business and harmful to Coca-Cola. PepsiCo&#39;s robust snack division has thrived since the pandemic&#39;s onset. Folks are spending more time working, learning, and entertaining at home, and so it is creating more opportunities to have a snack.</p><p>What&#39;s more, PepsiCo&#39;s snack division runs a higher operating profit margin than its beverage segment. In its 36 weeks ended Sept. 4, PepsiCo&#39;s snack segment (Frito-Lay) reported revenue of $13.4 billion and operating income of $4 billion. In contrast, its beverage segment reported revenue of $17.6 billion and operating income of $1.9 billion. These figures are for North America alone.</p><p>Meanwhile, the effects of the pandemic have been harmful to Coca-Cola. The company has spent decades securing exclusive relationships with venue operators worldwide, including movie theaters, ballparks, theme parks, and restaurants, along with college campuses. So when governments mandated the closures of nonessential businesses, sales fell for Coca-Cola and its partners. In 2020, Coke&#39;s sales were down by 11.4%.</p><h2>Why will 2022 be any different for Coca-Cola?</h2><p>Thankfully, several effective vaccines and treatments against COVID-19 have been developed and administered worldwide. That has given governments the confidence to reopen economies and keep them open despite several surges of COVID infection. Economic reopening started gaining momentum in the second quarter of 2021, first in regions with better access to vaccines and moving on to the rest of the world as the year progressed.</p><p>Fans can again watch their favorite teams live and in person. People can go to see musicians in concert, and restaurants are welcoming guests to dine on premises, both inside and outside. Although this return to routine has been progressing throughout 2021, away-from-home sales of beverages are still below pre-pandemic levels, according to Coca-Cola CEO James Quincey.</p><p>However, if economic reopening continues to gain momentum in 2022, away-from-home beverage sales will likely surpass 2019 levels. And remember that beverages cost much more when you buy them for consumption outside of your home. A Coke at a movie theater can hit your wallet for $6, while the same quantity can be had for less than $2 at a grocery store.</p><p>Simultaneously, as people are spending more time away from home, returning to offices -- and with students going back to school on campus -- there will be fewer opportunities to eat at home, thereby slowing sales for PepsiCo&#39;s lucrative snack segment.</p><p>The combination of increasing beverage sales for Coca-Cola and decreasing sales in PepsiCo&#39;s snack segment could be the catalyst that causes Coca-Cola&#39;s stock to outperform PepsiCo in 2022.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2022 Market Prediction: Coca-Cola Outperforms PepsiCo</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2022 Market Prediction: Coca-Cola Outperforms PepsiCo\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-13 11:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/12/2022-market-prediction-coca-cola-outperforms-pepsi/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>International consumer packaged-goods giants Coca-Cola (NYSE:KO) and PepsiCo (NASDAQ:PEP) have competed for decades. The two are similar regarding the beverages they sell worldwide. The one ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/12/2022-market-prediction-coca-cola-outperforms-pepsi/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PEP":"百事可乐","KO":"可口可乐"},"source_url":"https://www.fool.com/investing/2022/01/12/2022-market-prediction-coca-cola-outperforms-pepsi/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2202730280","content_text":"International consumer packaged-goods giants Coca-Cola (NYSE:KO) and PepsiCo (NASDAQ:PEP) have competed for decades. The two are similar regarding the beverages they sell worldwide. The one significant difference is that PepsiCo has a robust snack segment.In 2021, PepsiCo's stock returned 17%, handily outperforming Coca-Cola's return of 8%. That being said, I'm going to go out on a limb and predict that Coca-Cola will turn the tables in 2022.Stay-at-home trends were good for PepsiCo's businessThe effects of the pandemic were helpful to PepsiCo's business and harmful to Coca-Cola. PepsiCo's robust snack division has thrived since the pandemic's onset. Folks are spending more time working, learning, and entertaining at home, and so it is creating more opportunities to have a snack.What's more, PepsiCo's snack division runs a higher operating profit margin than its beverage segment. In its 36 weeks ended Sept. 4, PepsiCo's snack segment (Frito-Lay) reported revenue of $13.4 billion and operating income of $4 billion. In contrast, its beverage segment reported revenue of $17.6 billion and operating income of $1.9 billion. These figures are for North America alone.Meanwhile, the effects of the pandemic have been harmful to Coca-Cola. The company has spent decades securing exclusive relationships with venue operators worldwide, including movie theaters, ballparks, theme parks, and restaurants, along with college campuses. So when governments mandated the closures of nonessential businesses, sales fell for Coca-Cola and its partners. In 2020, Coke's sales were down by 11.4%.Why will 2022 be any different for Coca-Cola?Thankfully, several effective vaccines and treatments against COVID-19 have been developed and administered worldwide. That has given governments the confidence to reopen economies and keep them open despite several surges of COVID infection. Economic reopening started gaining momentum in the second quarter of 2021, first in regions with better access to vaccines and moving on to the rest of the world as the year progressed.Fans can again watch their favorite teams live and in person. People can go to see musicians in concert, and restaurants are welcoming guests to dine on premises, both inside and outside. Although this return to routine has been progressing throughout 2021, away-from-home sales of beverages are still below pre-pandemic levels, according to Coca-Cola CEO James Quincey.However, if economic reopening continues to gain momentum in 2022, away-from-home beverage sales will likely surpass 2019 levels. And remember that beverages cost much more when you buy them for consumption outside of your home. A Coke at a movie theater can hit your wallet for $6, while the same quantity can be had for less than $2 at a grocery store.Simultaneously, as people are spending more time away from home, returning to offices -- and with students going back to school on campus -- there will be fewer opportunities to eat at home, thereby slowing sales for PepsiCo's lucrative snack segment.The combination of increasing beverage sales for Coca-Cola and decreasing sales in PepsiCo's snack segment could be the catalyst that causes Coca-Cola's stock to outperform PepsiCo in 2022.","news_type":1},"isVote":1,"tweetType":1,"viewCount":768,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006299673,"gmtCreate":1641742627231,"gmtModify":1676533644113,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"Thx","listText":"Thx","text":"Thx","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006299673","repostId":"2201249471","repostType":4,"isVote":1,"tweetType":1,"viewCount":818,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006102718,"gmtCreate":1641622404944,"gmtModify":1676533635831,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"Fingers crossed","listText":"Fingers crossed","text":"Fingers crossed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006102718","repostId":"1134509683","repostType":4,"repost":{"id":"1134509683","kind":"news","pubTimestamp":1641612579,"share":"https://ttm.financial/m/news/1134509683?lang=&edition=fundamental","pubTime":"2022-01-08 11:29","market":"us","language":"en","title":"3 COVID Stocks That Will Make Billions in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1134509683","media":"Motley Fool","summary":"These three COVID-19 stocks could rake in a tremendous amount of cash this year.","content":"<html><head></head><body><p>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><b>A safe harbor in stormy weather</b></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><b>The antibody market all to itself</b></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Will Make Billions in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Will Make Billions in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-08 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药","VIR":"Vir Biotechnology, Inc."},"source_url":"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134509683","content_text":"It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.Pfizer(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy Novavax(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in Vir Biotechnology(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.IMAGE SOURCE: GETTY IMAGES.A safe harbor in stormy weatherGeorge Budwell(Pfizer):Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.What's more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.But less than three weeks out from the drug's initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.So, if you're looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.Revenue forecasts for Novavax:  $2 billion to $8 billionTaylor Carmichael(Novavax):Novavax is on the verge of greatness this year. The company's stock price is down to $125 a share. That's where it started in 2021, so last year was pretty much a washout for the stock.Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it's highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company's already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that's over $4 billion in sales, just in Europe.Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company's market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.The antibody market all to itselfPatrick Bafuma(Vir Biotechnology):The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from Eli Lilly (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from RocheandRegeneron are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--GlaxoSmithKline and Vir Biotechnology's sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it's the only one left right now to fight the omicron variant.Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly's antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.And while Pfizer's Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who's who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid's possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":929,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001771356,"gmtCreate":1641338362659,"gmtModify":1676533599479,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"Thx","listText":"Thx","text":"Thx","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001771356","repostId":"1176338665","repostType":4,"isVote":1,"tweetType":1,"viewCount":807,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003501001,"gmtCreate":1641004664879,"gmtModify":1676533563172,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"Thx","listText":"Thx","text":"Thx","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003501001","repostId":"2195410116","repostType":4,"isVote":1,"tweetType":1,"viewCount":667,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9006102718,"gmtCreate":1641622404944,"gmtModify":1676533635831,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"Fingers crossed","listText":"Fingers crossed","text":"Fingers crossed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006102718","repostId":"1134509683","repostType":4,"repost":{"id":"1134509683","kind":"news","pubTimestamp":1641612579,"share":"https://ttm.financial/m/news/1134509683?lang=&edition=fundamental","pubTime":"2022-01-08 11:29","market":"us","language":"en","title":"3 COVID Stocks That Will Make Billions in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1134509683","media":"Motley Fool","summary":"These three COVID-19 stocks could rake in a tremendous amount of cash this year.","content":"<html><head></head><body><p>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><b>A safe harbor in stormy weather</b></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><b>The antibody market all to itself</b></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Will Make Billions in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Will Make Billions in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-08 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药","VIR":"Vir Biotechnology, Inc."},"source_url":"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134509683","content_text":"It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.Pfizer(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy Novavax(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in Vir Biotechnology(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.IMAGE SOURCE: GETTY IMAGES.A safe harbor in stormy weatherGeorge Budwell(Pfizer):Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.What's more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.But less than three weeks out from the drug's initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.So, if you're looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.Revenue forecasts for Novavax:  $2 billion to $8 billionTaylor Carmichael(Novavax):Novavax is on the verge of greatness this year. The company's stock price is down to $125 a share. That's where it started in 2021, so last year was pretty much a washout for the stock.Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it's highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company's already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that's over $4 billion in sales, just in Europe.Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company's market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.The antibody market all to itselfPatrick Bafuma(Vir Biotechnology):The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from Eli Lilly (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from RocheandRegeneron are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--GlaxoSmithKline and Vir Biotechnology's sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it's the only one left right now to fight the omicron variant.Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly's antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.And while Pfizer's Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who's who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid's possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":929,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9004334051,"gmtCreate":1642503694600,"gmtModify":1676533716109,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"Thx","listText":"Thx","text":"Thx","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004334051","repostId":"1167491225","repostType":4,"isVote":1,"tweetType":1,"viewCount":410,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001771356,"gmtCreate":1641338362659,"gmtModify":1676533599479,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"Thx","listText":"Thx","text":"Thx","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001771356","repostId":"1176338665","repostType":4,"repost":{"id":"1176338665","kind":"news","pubTimestamp":1641335954,"share":"https://ttm.financial/m/news/1176338665?lang=&edition=fundamental","pubTime":"2022-01-05 06:39","market":"fut","language":"en","title":"Goldman Says Bitcoin $100,000 a Possibility by Taking on Gold","url":"https://stock-news.laohu8.com/highlight/detail?id=1176338665","media":"Bloomberg","summary":"Firm expects Bitcoin to take more market share from gold‘Store of value’ market share seen being up ","content":"<html><head></head><body><ul><li>Firm expects Bitcoin to take more market share from gold</li><li>‘Store of value’ market share seen being up for grabs</li></ul><p>Bitcoin will continue to take market share from gold as part of broader adoption of digital assets, making the often touted price prediction of a $100,000 by advocates a possibility, according to Goldman Sachs Group.</p><p>Goldman estimates that Bitcoin’s float-adjusted market capitalization is just under $700 billion. That accounts for 20% share of the “store of value” market which it said is comprised of Bitcoin and gold. The value of gold that’s available for investment is estimated at $2.6 trillion.</p><p>If Bitcoin’s share of the store of value market were “hypothetically” to rise to 50% over the next five years, its price would increase to just over $100,000, for a compound annualized return of 17% or 18%, Zach Pandl, co-head of global FX and EM strategy, wrote in a note Tuesday.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c73cbc4149351f2fc0c3ddfa2605dd2f\" tg-width=\"1000\" tg-height=\"703\" width=\"100%\" height=\"auto\"/><span>Source: Goldman</span></p><p>Bitcoin traded around $46,000 on Tuesday in New York, after climbing about 60% last year. The largest digital asset by market value hit a record of almost $69,000 in November. It has surged more than 4,700% since 2016.</p><p>Although the Bitcoin network’s consumption of real resources may be an obstacle to institutional adoption, that won’t stop the demand for the asset, the note said.</p><p>Bitcoin has long been referred to as digital gold. And the criticisms levied at gold tend to apply to Bitcoin as well: It pays no interest or dividends, and it doesn’t imitate the performance of more traditional assets. Advocates say Bitcoin, like gold, serves as protection against the systemic abuse of fiat currencies.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Says Bitcoin $100,000 a Possibility by Taking on Gold</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Says Bitcoin $100,000 a Possibility by Taking on Gold\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-05 06:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-01-04/goldman-says-bitcoin-100-000-a-possibility-by-taking-on-gold?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Firm expects Bitcoin to take more market share from gold‘Store of value’ market share seen being up for grabsBitcoin will continue to take market share from gold as part of broader adoption of digital...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-01-04/goldman-says-bitcoin-100-000-a-possibility-by-taking-on-gold?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GBTC":"Grayscale Bitcoin Trust"},"source_url":"https://www.bloomberg.com/news/articles/2022-01-04/goldman-says-bitcoin-100-000-a-possibility-by-taking-on-gold?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176338665","content_text":"Firm expects Bitcoin to take more market share from gold‘Store of value’ market share seen being up for grabsBitcoin will continue to take market share from gold as part of broader adoption of digital assets, making the often touted price prediction of a $100,000 by advocates a possibility, according to Goldman Sachs Group.Goldman estimates that Bitcoin’s float-adjusted market capitalization is just under $700 billion. That accounts for 20% share of the “store of value” market which it said is comprised of Bitcoin and gold. The value of gold that’s available for investment is estimated at $2.6 trillion.If Bitcoin’s share of the store of value market were “hypothetically” to rise to 50% over the next five years, its price would increase to just over $100,000, for a compound annualized return of 17% or 18%, Zach Pandl, co-head of global FX and EM strategy, wrote in a note Tuesday.Source: GoldmanBitcoin traded around $46,000 on Tuesday in New York, after climbing about 60% last year. The largest digital asset by market value hit a record of almost $69,000 in November. It has surged more than 4,700% since 2016.Although the Bitcoin network’s consumption of real resources may be an obstacle to institutional adoption, that won’t stop the demand for the asset, the note said.Bitcoin has long been referred to as digital gold. And the criticisms levied at gold tend to apply to Bitcoin as well: It pays no interest or dividends, and it doesn’t imitate the performance of more traditional assets. Advocates say Bitcoin, like gold, serves as protection against the systemic abuse of fiat currencies.","news_type":1},"isVote":1,"tweetType":1,"viewCount":807,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003501001,"gmtCreate":1641004664879,"gmtModify":1676533563172,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"Thx","listText":"Thx","text":"Thx","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003501001","repostId":"2195410116","repostType":4,"repost":{"id":"2195410116","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1640963744,"share":"https://ttm.financial/m/news/2195410116?lang=&edition=fundamental","pubTime":"2021-12-31 23:15","market":"us","language":"en","title":"Wall Street analysts' favorite stocks for 2022 include Alaska Air, Caesars and Lithia Motors","url":"https://stock-news.laohu8.com/highlight/detail?id=2195410116","media":"Dow Jones","summary":"General Motors, Salesforce and PayPal are among the 20 S&P 500 stocks that analysts both heavily fav","content":"<html><head></head><body><p>General Motors, <a href=\"https://laohu8.com/S/CRM\">Salesforce</a> and <a href=\"https://laohu8.com/S/PYPL\">PayPal</a> are among the 20 S&amp;P 500 stocks that analysts both heavily favor and expect to rise to the most</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d68bea2d0c6b7347ed8e660ad6323ef6\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"/><span>Wall Street analysts on average expect the stock price of Caesars Entertainment to climb 48% over the next 12 months.</span></p><p>As the coronavirus pandemic has stretched out, investors have continued to pour money into stocks, in part because the alternatives have been dismal. Why bother with 10-year U.S. Treasury bonds that yield a paltry 1.52% when the S&amp;P 500 index has a dividend yield of 1.30% to go along with its growth potential?</p><p>Things may change in 2022 as the Federal Reserve winds down its bond purchases that have kept long-term interest rates low. Then again, U.S. stocks have continued to rise since the Fed announced its policy changes on Dec. 15.</p><p>With U.S. bond yields already so much higher than they are in the rest of the developed world, foreign investors may continue to buy U.S. bonds and keep yields at historically low levels. And that might make for a continued flow of money into U.S. stocks.</p><p>Below are lists of stocks among the benchmark S&amp;P 500 , the S&amp;P 400 Mid Cap Index <a href=\"https://laohu8.com/S/MID\">$(MID)$</a> and the S&amp;P Small Cap 600 Index  that are rated &#34;buy&#34; or the equivalent by at least three out of four of Wall Street analysts polled by FactSet that are expected to rise the most over the next year. Those lists are followed by a summary of analysts&#39; opinions of all 30 stocks in the Dow Jones Industrial Average.</p><p><b>Large-cap favorites</b></p><p>Among the S&amp;P 500, 93 stocks are rated a &#34;buy&#34; or the equivalent by at least 75% of analysts working for brokerage firms. Here are the 20 the analysts expect to rise the most over the next year, based on consensus price targets:</p><table><tbody><tr><td>Company</td><td>Ticker</td><td>Industry</td><td>Closing price -- Dec. 30</td><td>Consensus price target</td><td>Implied 12-month upside potential</td><td>Share &#34;buy&#34; ratings</td><td>Total return -- 2021 through Dec. 30</td></tr><tr><td>Alaska Air Group Inc.</td><td>ALK</td><td>Airlines</td><td>$51.94</td><td>$77.71</td><td>50%</td><td>93%</td><td>0%</td></tr><tr><td>Caesars Entertainment Inc.</td><td>CZR</td><td>Casinos/ Gaming</td><td>$92.99</td><td>$137.36</td><td>48%</td><td>94%</td><td>25%</td></tr><tr><td>Generac Holdings Inc.</td><td>GNRC</td><td>Electrical Products</td><td>$352.96</td><td>$514.11</td><td>46%</td><td>77%</td><td>55%</td></tr><tr><td>PayPal Holdings Inc.</td><td>PYPL</td><td>Data Processing Services</td><td>$191.88</td><td>$273.65</td><td>43%</td><td>84%</td><td>-18%</td></tr><tr><td><a href=\"https://laohu8.com/S/TMUSR\">T-Mobile US Inc</a>.</td><td>TMUS</td><td>Wireless Telecommunications</td><td>$116.51</td><td>$165.51</td><td>42%</td><td>81%</td><td>-14%</td></tr><tr><td>News Corp. Class A</td><td>NWSA</td><td>Publishing: Newspapers</td><td>$22.50</td><td>$31.91</td><td>42%</td><td>88%</td><td>26%</td></tr><tr><td>Global Payments Inc.</td><td>GPN</td><td>Data Processing Services</td><td>$136.29</td><td>$188.41</td><td>38%</td><td>85%</td><td>-36%</td></tr><tr><td>Southwest Airlines Co.</td><td>LUV</td><td>Airlines</td><td>$42.72</td><td>$57.32</td><td>34%</td><td>78%</td><td>-8%</td></tr><tr><td>Schlumberger NV</td><td>SLB</td><td>Oilfield Services/ Equipment</td><td>$29.82</td><td>$39.58</td><td>33%</td><td>85%</td><td>39%</td></tr><tr><td>Salesforce.com Inc.</td><td>CRM</td><td>Software</td><td>$255.33</td><td>$331.46</td><td>30%</td><td>86%</td><td>15%</td></tr><tr><td>Bath &amp; Body Works Inc.</td><td>BBWI</td><td>Apparel, Footwear Retail</td><td>$69.70</td><td>$90.21</td><td>29%</td><td>86%</td><td>133%</td></tr><tr><td>Electronic Arts Inc.</td><td>EA</td><td>Recreational Products</td><td>$134.46</td><td>$173.78</td><td>29%</td><td>77%</td><td>-6%</td></tr><tr><td><a href=\"https://laohu8.com/S/PSX\">Phillips 66</a></td><td>PSX</td><td>Oil Refining/ Marketing</td><td>$72.45</td><td>$93.50</td><td>29%</td><td>79%</td><td>8%</td></tr><tr><td>Medtronic <a href=\"https://laohu8.com/S/PLC\">PLC</a></td><td>MDT</td><td>Medical Specialties</td><td>$104.47</td><td>$134.52</td><td>29%</td><td>85%</td><td>-9%</td></tr><tr><td>Teleflex Inc.</td><td>TFX</td><td>Medical Specialties</td><td>$330.89</td><td>$424.11</td><td>28%</td><td>75%</td><td>-19%</td></tr><tr><td>General Motors Co.</td><td>GM</td><td>Motor Vehicles</td><td>$58.13</td><td>$74.45</td><td>28%</td><td>84%</td><td>40%</td></tr><tr><td>Pioneer Natural Resources Co.</td><td>PXD</td><td>Oil &amp; Gas Production</td><td>$181.28</td><td>$231.61</td><td>28%</td><td>86%</td><td>66%</td></tr><tr><td><a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a></td><td>SYF</td><td>Finance, Rental, Leasing</td><td>$46.26</td><td>$58.74</td><td>27%</td><td>77%</td><td>36%</td></tr><tr><td>Comcast Corp. Class A</td><td>CMCSA</td><td>Cable, Satellite TV</td><td>$50.59</td><td>$64.08</td><td>27%</td><td>79%</td><td>-2%</td></tr><tr><td>EOG Resources Inc.</td><td>EOG</td><td>Oil &amp; Gas Production</td><td>$89.18</td><td>$112.94</td><td>27%</td><td>79%</td><td>89%</td></tr><tr><td></td><td>Source: FactSet</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table><p>Alaska Air Group Inc. tops the list of analysts&#39; favorite large-cap stocks for 2022. The shares were flat for 2021, as investors were understandably disappointed that the travel industry&#39;s recovery was stalled by new waves of coronavirus infections. Other travel and hospitality-related recovery plays on the list include Caesars Entertainment Inc.  and Southwest Airlines Co..</p><p>There are four oil-related stocks on the list, three of which rose significantly during 2021. West Texas Crude oil  was up 59% for 2021 through Dec. 30 based on forward-month contracts, while the S&amp;P 500 energy sector returned 54%.</p><p>Other stocks on the list that performed very well during 2021 and are expected to do so again in 2022 include Generac Holdings Inc., Bath &amp; Body Works Inc. and General Motors Co..</p><p><b>Midcap stocks expected to show the biggest gains</b></p><p>The lists of &#34;favorite&#34; stocks are confined to those covered by at least five analysts. Among components of the S&amp;P 400 Mid Cap Index, that leaves 92 stocks with at least 75% &#34;buy&#34; ratings. Here at the 20 expected to rise the most over the next year:</p><table><tbody><tr><td>Company</td><td>Ticker</td><td>Industry</td><td>Closing price -- Dec. 30</td><td>Consensus price target</td><td>Implied 12-month upside potential</td><td>Share &#34;buy&#34; ratings</td><td>Total return -- 2021 through Dec. 30</td></tr><tr><td><a href=\"https://laohu8.com/S/RUN\">Sunrun Inc.</a></td><td>RUN</td><td>Alternative Power Generation</td><td>$34.01</td><td>$72.61</td><td>113%</td><td>77%</td><td>-51%</td></tr><tr><td><a href=\"https://laohu8.com/S/APPS\">Digital Turbine Inc.</a></td><td>APPS</td><td>Software</td><td>$62.84</td><td>$104.00</td><td>65%</td><td>100%</td><td>11%</td></tr><tr><td>Jazz Pharmaceuticals Public Ltd. Co.</td><td>JAZZ</td><td>Pharmaceuticals</td><td>$128.26</td><td>$200.89</td><td>57%</td><td>90%</td><td>-22%</td></tr><tr><td>Lithia Motors Inc.</td><td>LAD</td><td>Specialty Stores</td><td>$297.17</td><td>$460.31</td><td>55%</td><td>80%</td><td>2%</td></tr><tr><td><a href=\"https://laohu8.com/S/CRNC\">Cerence Inc.</a></td><td>CRNC</td><td>Software</td><td>$77.59</td><td>$119.42</td><td>54%</td><td>100%</td><td>-23%</td></tr><tr><td>Callaway Golf Co.</td><td>ELY</td><td>Recreational Products</td><td>$27.63</td><td>$41.50</td><td>50%</td><td>77%</td><td>15%</td></tr><tr><td>Ziff Davis Inc.</td><td>ZD</td><td>Internet Software, Services</td><td>$111.37</td><td>$166.88</td><td>50%</td><td>100%</td><td>31%</td></tr><tr><td>Victoria&#39;s Secret &amp; Co.</td><td>VSCO</td><td>Apparel, Footwear Retail</td><td>$55.46</td><td>$82.73</td><td>49%</td><td>82%</td><td>N/A</td></tr><tr><td>LiveRamp Holdings Inc.</td><td>RAMP</td><td>Data Processing Services</td><td>$49.07</td><td>$73.18</td><td>49%</td><td>82%</td><td>-33%</td></tr><tr><td>PROG Holdings Inc.</td><td>PRG</td><td>Finance, Rental, Leasing</td><td>$44.84</td><td>$66.29</td><td>48%</td><td>75%</td><td>-17%</td></tr></tbody></table><table><tbody><tr><td><a href=\"https://laohu8.com/S/MLKN\">MillerKnoll</a> Inc.</td><td>MLKN</td><td>Office Equipment, Supplies</td><td>$38.98</td><td>$57.60</td><td>48%</td><td>80%</td><td>17%</td></tr><tr><td>ChampionX Corp.</td><td>CHX</td><td>Chemicals: Specialty</td><td>$20.01</td><td>$29.00</td><td>45%</td><td>80%</td><td>31%</td></tr><tr><td>Darling Ingredients Inc.</td><td>DAR</td><td>Agricultural Commodities, Milling</td><td>$67.87</td><td>$96.79</td><td>43%</td><td>100%</td><td>18%</td></tr><tr><td>Axon Enterprise Inc.</td><td>AXON</td><td>Aerospace &amp; Defense</td><td>$156.07</td><td>$222.40</td><td>43%</td><td>91%</td><td>27%</td></tr><tr><td>EQT Corp.</td><td>EQT</td><td>Oil &amp; Gas Production</td><td>$22.04</td><td>$31.30</td><td>42%</td><td>75%</td><td>73%</td></tr><tr><td><a href=\"https://laohu8.com/S/IAA\">IAA Inc</a>.</td><td>IAA</td><td>Specialty Stores</td><td>$50.43</td><td>$70.88</td><td>41%</td><td>90%</td><td>-22%</td></tr><tr><td><a href=\"https://laohu8.com/S/HQY\">HealthEquity</a> Inc.</td><td>HQY</td><td>Investment Managers</td><td>$43.86</td><td>$61.50</td><td>40%</td><td>75%</td><td>-37%</td></tr><tr><td><a href=\"https://laohu8.com/S/AZTA\">Azenta</a> Inc.</td><td>AZTA</td><td>Electronic Production Equipment</td><td>$103.18</td><td>$144.60</td><td>40%</td><td>83%</td><td>53%</td></tr><tr><td>Vontier Corp</td><td>VNT</td><td>Transportation</td><td>$30.89</td><td>$42.82</td><td>39%</td><td>77%</td><td>-7%</td></tr><tr><td>SailPoint Technologies Holdings Inc.</td><td>SAIL</td><td>Software</td><td>$48.85</td><td>$67.67</td><td>39%</td><td>93%</td><td>-8%</td></tr><tr><td></td><td>Source: FactSet</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table><p><b>Small-cap favorites for 2022</b></p><p>Among the S&amp;P Small Cap 600, 101 stocks covered by at least five analysts have at least 75% &#34;buy&#34; ratings. Analysts expect these 20 of the favored stocks to rise the most over the next 12 months:</p><table><tbody><tr><td>Company</td><td>Ticker</td><td>Industry</td><td>Closing price -- Dec. 30</td><td>Consensus price target</td><td>Implied 12-month upside potential</td><td>Share &#34;buy&#34; ratings</td><td>Total return -- 2021 through Dec. 30</td></tr><tr><td>UniQure NV</td><td>QURE</td><td>Biotechnology</td><td>$20.87</td><td>$63.78</td><td>206%</td><td>89%</td><td>-42%</td></tr><tr><td><a href=\"https://laohu8.com/S/TCMD\">Tactile Systems Technology Inc</a>.</td><td>TCMD</td><td>Medical Specialties</td><td>$19.23</td><td>$52.25</td><td>172%</td><td>100%</td><td>-57%</td></tr><tr><td>Zynex Inc.</td><td>ZYXI</td><td>Medical Specialties</td><td>$10.23</td><td>$22.20</td><td>117%</td><td>80%</td><td>-24%</td></tr><tr><td>Cara Therapeutics Inc.</td><td>CARA</td><td>Biotechnology</td><td>$12.34</td><td>$26.25</td><td>113%</td><td>75%</td><td>-18%</td></tr><tr><td><a href=\"https://laohu8.com/S/TREE\">LendingTree</a> Inc.</td><td>TREE</td><td>Finance, Rental, Leasing</td><td>$121.91</td><td>$238.75</td><td>96%</td><td>100%</td><td>-55%</td></tr><tr><td>Joint Corp</td><td>JYNT</td><td>Hospital, Nursing Management</td><td>$64.62</td><td>$126.00</td><td>95%</td><td>83%</td><td>146%</td></tr><tr><td>Talos Energy Inc.</td><td>TALO</td><td>Oil &amp; Gas Production</td><td>$10.07</td><td>$19.00</td><td>89%</td><td>100%</td><td>22%</td></tr><tr><td><a href=\"https://laohu8.com/S/REGI\">Renewable Energy Group</a> Inc.</td><td>REGI</td><td>Chemicals</td><td>$42.78</td><td>$79.86</td><td>87%</td><td>80%</td><td>-40%</td></tr><tr><td><a href=\"https://laohu8.com/S/LPSN\">LivePerson</a> Inc.</td><td>LPSN</td><td>Internet Software, Services</td><td>$36.59</td><td>$64.31</td><td>76%</td><td>79%</td><td>-41%</td></tr><tr><td><a href=\"https://laohu8.com/S/BLFS\">BioLife Solutions Inc.</a></td><td>BLFS</td><td>Medical Specialties</td><td>$37.44</td><td>$63.43</td><td>69%</td><td>78%</td><td>-6%</td></tr><tr><td>OptimizeRx Corp.</td><td>OPRX</td><td>Data Processing Services</td><td>$61.14</td><td>$103.00</td><td>68%</td><td>100%</td><td>96%</td></tr><tr><td>Cutera Inc.</td><td>CUTR</td><td>Medical Specialties</td><td>$39.26</td><td>$63.40</td><td>61%</td><td>100%</td><td>63%</td></tr><tr><td><a href=\"https://laohu8.com/S/SEM\">Select Medical Holdings</a> Corp.</td><td>SEM</td><td>Hospital, Nursing Management</td><td>$29.82</td><td>$47.40</td><td>59%</td><td>80%</td><td>9%</td></tr><tr><td>Hibbett Inc.</td><td>HIBB</td><td>Specialty Stores</td><td>$72.00</td><td>$112.17</td><td>56%</td><td>83%</td><td>57%</td></tr><tr><td><a href=\"https://laohu8.com/S/PLMR\">Palomar Holdings</a> Inc.</td><td>PLMR</td><td>Property/ Casualty Insurance</td><td>$63.76</td><td>$99.14</td><td>55%</td><td>78%</td><td>-28%</td></tr><tr><td>Coherus BioSciences Inc.</td><td>CHRS</td><td>Biotechnology</td><td>$16.74</td><td>$25.43</td><td>52%</td><td>86%</td><td>-4%</td></tr><tr><td>Celsius Holdings Inc.</td><td>CELH</td><td>Beverages: Non-Alcoholic</td><td>$73.52</td><td>$110.21</td><td>50%</td><td>75%</td><td>46%</td></tr><tr><td>James River Group Holdings Ltd.</td><td>JRVR</td><td>Property/ Casualty Insurance</td><td>$28.14</td><td>$41.86</td><td>49%</td><td>75%</td><td>-41%</td></tr><tr><td><a href=\"https://laohu8.com/S/NEO\">NeoGenomics</a> Inc.</td><td>NEO</td><td>Medical/ Nursing Services</td><td>$34.15</td><td>$50.18</td><td>47%</td><td>92%</td><td>-37%</td></tr><tr><td>Vericel Corp.</td><td>VCEL</td><td>Medical Specialties</td><td>$40.11</td><td>$58.46</td><td>46%</td><td>100%</td><td>30%</td></tr><tr><td></td><td>Source: FactSet</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table><p><b>All 30 components of the Dow Jones Industrial Average</b></p><p>Here they are, ranked by how much analysts expect them to rise over the next year:</p><table><tbody><tr><td>Company</td><td>Ticker</td><td>Industry</td><td>Closing price -- Dec. 30</td><td>Consensus price target</td><td>Implied 12-month upside potential</td><td>Share &#34;buy&#34; ratings</td><td>Total return -- 2021 through Dec. 30</td></tr><tr><td>Salesforce.com Inc.</td><td>CRM</td><td>Software</td><td>$255.33</td><td>$331.46</td><td>30%</td><td>86%</td><td>15%</td></tr><tr><td>Boeing Co.</td><td>BA</td><td>Aerospace &amp; Defense</td><td>$202.71</td><td>$259.61</td><td>28%</td><td>73%</td><td>-5%</td></tr><tr><td><a href=\"https://laohu8.com/S/V\">Visa</a> Inc. Class A</td><td>V</td><td>Finance, Rental, Leasing</td><td>$217.87</td><td>$272.62</td><td>25%</td><td>92%</td><td>0%</td></tr><tr><td>Walt Disney Co.</td><td>DIS</td><td>Cable, Satellite TV</td><td>$155.93</td><td>$193.29</td><td>24%</td><td>70%</td><td>-14%</td></tr><tr><td>Merck &amp; Co. Inc.</td><td>MRK</td><td>Pharmaceuticals</td><td>$77.14</td><td>$92.70</td><td>20%</td><td>60%</td><td>2%</td></tr><tr><td>Goldman Sachs Group Inc.</td><td>GS</td><td>Investment Banks, Brokers</td><td>$385.52</td><td>$458.97</td><td>19%</td><td>67%</td><td>49%</td></tr><tr><td>Walmart Inc.</td><td>WMT</td><td>Food Retail</td><td>$143.17</td><td>$169.92</td><td>19%</td><td>80%</td><td>1%</td></tr><tr><td>Dow Inc.</td><td>DOW</td><td>Chemicals</td><td>$56.78</td><td>$66.62</td><td>17%</td><td>36%</td><td>7%</td></tr><tr><td>American Express Co.</td><td>AXP</td><td>Finance, Rental, Leasing</td><td>$164.16</td><td>$191.35</td><td>17%</td><td>46%</td><td>37%</td></tr><tr><td>Honeywell International Inc.</td><td>HON</td><td>Industrial Conglomerates</td><td>$207.11</td><td>$238.27</td><td>15%</td><td>48%</td><td>-1%</td></tr></tbody></table><p><table><tbody><tr><td>Caterpillar Inc.</td><td>CAT</td><td>Trucks, Construction, Farm Machinery</td><td>$206.08</td><td>$235.57</td><td>14%</td><td>52%</td><td>16%</td></tr><tr><td>Verizon Communications Inc.</td><td>VZ</td><td>Telecommunications</td><td>$52.25</td><td>$59.57</td><td>14%</td><td>27%</td><td>-7%</td></tr><tr><td>JPMorgan Chase &amp; Co.</td><td>JPM</td><td>Major Banks</td><td>$158.48</td><td>$179.70</td><td>13%</td><td>61%</td><td>28%</td></tr><tr><td>Chevron Corp.</td><td>CVX</td><td>Integrated Oil</td><td>$117.43</td><td>$130.74</td><td>11%</td><td>67%</td><td>46%</td></tr><tr><td>Nike Inc. Class B</td><td>NKE</td><td>Apparel, Footwear</td><td>$167.49</td><td>$185.89</td><td>11%</td><td>77%</td><td>19%</td></tr><tr><td>Microsoft Corp.</td><td>MSFT</td><td>Software</td><td>$339.32</td><td>$370.51</td><td>9%</td><td>90%</td><td>54%</td></tr><tr><td>3M Co.</td><td>MMM</td><td>Industrial Conglomerates</td><td>$177.64</td><td>$192.06</td><td>8%</td><td>14%</td><td>5%</td></tr><tr><td>Coca-Cola Co.</td><td>KO</td><td>Beverages: Non-Alcoholic</td><td>$58.78</td><td>$62.67</td><td>7%</td><td>61%</td><td>11%</td></tr><tr><td>Johnson &amp; Johnson</td><td>JNJ</td><td>Pharmaceuticals</td><td>$172.31</td><td>$183.71</td><td>7%</td><td>50%</td><td>12%</td></tr><tr><td>Intel Corp.</td><td>INTC</td><td>Semiconductors</td><td>$51.74</td><td>$54.91</td><td>6%</td><td>27%</td><td>7%</td></tr><tr><td>International Business Machines Corp.</td><td>IBM</td><td>Information Technology Services</td><td>$133.91</td><td>$142.07</td><td>6%</td><td>28%</td><td>17%</td></tr><tr><td>Amgen Inc.</td><td>AMGN</td><td>Biotechnology</td><td>$226.47</td><td>$238.09</td><td>5%</td><td>31%</td><td>2%</td></tr><tr><td>Travelers Companies Inc.</td><td>TRV</td><td>Multi-Line Insurance</td><td>$156.81</td><td>$164.06</td><td>5%</td><td>26%</td><td>14%</td></tr><tr><td>McDonald’s Corp.</td><td>MCD</td><td>Restaurants</td><td>$267.21</td><td>$276.06</td><td>3%</td><td>70%</td><td>27%</td></tr><tr><td>Home Depot Inc.</td><td>HD</td><td>Home Improvement Chains</td><td>$409.94</td><td>$416.83</td><td>2%</td><td>65%</td><td>58%</td></tr><tr><td>Walgreens Boots Alliance Inc.</td><td>WBA</td><td>Drugstore Chains</td><td>$51.99</td><td>$52.80</td><td>2%</td><td>5%</td><td>35%</td></tr><tr><td>UnitedHealth Group Inc.</td><td>UNH</td><td>Managed Health Care</td><td>$504.43</td><td>$504.20</td><td>0%</td><td>86%</td><td>46%</td></tr><tr><td>Apple Inc.</td><td>AAPL</td><td>Telecommunications Equipment</td><td>$178.20</td><td>$175.81</td><td>-1%</td><td>79%</td><td>35%</td></tr><tr><td>Cisco Systems Inc.</td><td>CSCO</td><td>Information Technology Services</td><td>$63.62</td><td>$62.69</td><td>-1%</td><td>54%</td><td>46%</td></tr><tr><td>Procter &amp; Gamble Co.</td><td>PG</td><td>Household, Personal Care</td><td>$162.77</td><td>$156.67</td><td>-4%</td><td>54%</td><td>20%</td></tr><tr><td>Source: FactSet</td></tr></tbody></table></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street analysts' favorite stocks for 2022 include Alaska Air, Caesars and Lithia Motors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street analysts' favorite stocks for 2022 include Alaska Air, Caesars and Lithia Motors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-31 23:15</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>General Motors, <a href=\"https://laohu8.com/S/CRM\">Salesforce</a> and <a href=\"https://laohu8.com/S/PYPL\">PayPal</a> are among the 20 S&amp;P 500 stocks that analysts both heavily favor and expect to rise to the most</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d68bea2d0c6b7347ed8e660ad6323ef6\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"/><span>Wall Street analysts on average expect the stock price of Caesars Entertainment to climb 48% over the next 12 months.</span></p><p>As the coronavirus pandemic has stretched out, investors have continued to pour money into stocks, in part because the alternatives have been dismal. Why bother with 10-year U.S. Treasury bonds that yield a paltry 1.52% when the S&amp;P 500 index has a dividend yield of 1.30% to go along with its growth potential?</p><p>Things may change in 2022 as the Federal Reserve winds down its bond purchases that have kept long-term interest rates low. Then again, U.S. stocks have continued to rise since the Fed announced its policy changes on Dec. 15.</p><p>With U.S. bond yields already so much higher than they are in the rest of the developed world, foreign investors may continue to buy U.S. bonds and keep yields at historically low levels. And that might make for a continued flow of money into U.S. stocks.</p><p>Below are lists of stocks among the benchmark S&amp;P 500 , the S&amp;P 400 Mid Cap Index <a href=\"https://laohu8.com/S/MID\">$(MID)$</a> and the S&amp;P Small Cap 600 Index  that are rated &#34;buy&#34; or the equivalent by at least three out of four of Wall Street analysts polled by FactSet that are expected to rise the most over the next year. Those lists are followed by a summary of analysts&#39; opinions of all 30 stocks in the Dow Jones Industrial Average.</p><p><b>Large-cap favorites</b></p><p>Among the S&amp;P 500, 93 stocks are rated a &#34;buy&#34; or the equivalent by at least 75% of analysts working for brokerage firms. Here are the 20 the analysts expect to rise the most over the next year, based on consensus price targets:</p><table><tbody><tr><td>Company</td><td>Ticker</td><td>Industry</td><td>Closing price -- Dec. 30</td><td>Consensus price target</td><td>Implied 12-month upside potential</td><td>Share &#34;buy&#34; ratings</td><td>Total return -- 2021 through Dec. 30</td></tr><tr><td>Alaska Air Group Inc.</td><td>ALK</td><td>Airlines</td><td>$51.94</td><td>$77.71</td><td>50%</td><td>93%</td><td>0%</td></tr><tr><td>Caesars Entertainment Inc.</td><td>CZR</td><td>Casinos/ Gaming</td><td>$92.99</td><td>$137.36</td><td>48%</td><td>94%</td><td>25%</td></tr><tr><td>Generac Holdings Inc.</td><td>GNRC</td><td>Electrical Products</td><td>$352.96</td><td>$514.11</td><td>46%</td><td>77%</td><td>55%</td></tr><tr><td>PayPal Holdings Inc.</td><td>PYPL</td><td>Data Processing Services</td><td>$191.88</td><td>$273.65</td><td>43%</td><td>84%</td><td>-18%</td></tr><tr><td><a href=\"https://laohu8.com/S/TMUSR\">T-Mobile US Inc</a>.</td><td>TMUS</td><td>Wireless Telecommunications</td><td>$116.51</td><td>$165.51</td><td>42%</td><td>81%</td><td>-14%</td></tr><tr><td>News Corp. Class A</td><td>NWSA</td><td>Publishing: Newspapers</td><td>$22.50</td><td>$31.91</td><td>42%</td><td>88%</td><td>26%</td></tr><tr><td>Global Payments Inc.</td><td>GPN</td><td>Data Processing Services</td><td>$136.29</td><td>$188.41</td><td>38%</td><td>85%</td><td>-36%</td></tr><tr><td>Southwest Airlines Co.</td><td>LUV</td><td>Airlines</td><td>$42.72</td><td>$57.32</td><td>34%</td><td>78%</td><td>-8%</td></tr><tr><td>Schlumberger NV</td><td>SLB</td><td>Oilfield Services/ Equipment</td><td>$29.82</td><td>$39.58</td><td>33%</td><td>85%</td><td>39%</td></tr><tr><td>Salesforce.com Inc.</td><td>CRM</td><td>Software</td><td>$255.33</td><td>$331.46</td><td>30%</td><td>86%</td><td>15%</td></tr><tr><td>Bath &amp; Body Works Inc.</td><td>BBWI</td><td>Apparel, Footwear Retail</td><td>$69.70</td><td>$90.21</td><td>29%</td><td>86%</td><td>133%</td></tr><tr><td>Electronic Arts Inc.</td><td>EA</td><td>Recreational Products</td><td>$134.46</td><td>$173.78</td><td>29%</td><td>77%</td><td>-6%</td></tr><tr><td><a href=\"https://laohu8.com/S/PSX\">Phillips 66</a></td><td>PSX</td><td>Oil Refining/ Marketing</td><td>$72.45</td><td>$93.50</td><td>29%</td><td>79%</td><td>8%</td></tr><tr><td>Medtronic <a href=\"https://laohu8.com/S/PLC\">PLC</a></td><td>MDT</td><td>Medical Specialties</td><td>$104.47</td><td>$134.52</td><td>29%</td><td>85%</td><td>-9%</td></tr><tr><td>Teleflex Inc.</td><td>TFX</td><td>Medical Specialties</td><td>$330.89</td><td>$424.11</td><td>28%</td><td>75%</td><td>-19%</td></tr><tr><td>General Motors Co.</td><td>GM</td><td>Motor Vehicles</td><td>$58.13</td><td>$74.45</td><td>28%</td><td>84%</td><td>40%</td></tr><tr><td>Pioneer Natural Resources Co.</td><td>PXD</td><td>Oil &amp; Gas Production</td><td>$181.28</td><td>$231.61</td><td>28%</td><td>86%</td><td>66%</td></tr><tr><td><a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a></td><td>SYF</td><td>Finance, Rental, Leasing</td><td>$46.26</td><td>$58.74</td><td>27%</td><td>77%</td><td>36%</td></tr><tr><td>Comcast Corp. Class A</td><td>CMCSA</td><td>Cable, Satellite TV</td><td>$50.59</td><td>$64.08</td><td>27%</td><td>79%</td><td>-2%</td></tr><tr><td>EOG Resources Inc.</td><td>EOG</td><td>Oil &amp; Gas Production</td><td>$89.18</td><td>$112.94</td><td>27%</td><td>79%</td><td>89%</td></tr><tr><td></td><td>Source: FactSet</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table><p>Alaska Air Group Inc. tops the list of analysts&#39; favorite large-cap stocks for 2022. The shares were flat for 2021, as investors were understandably disappointed that the travel industry&#39;s recovery was stalled by new waves of coronavirus infections. Other travel and hospitality-related recovery plays on the list include Caesars Entertainment Inc.  and Southwest Airlines Co..</p><p>There are four oil-related stocks on the list, three of which rose significantly during 2021. West Texas Crude oil  was up 59% for 2021 through Dec. 30 based on forward-month contracts, while the S&amp;P 500 energy sector returned 54%.</p><p>Other stocks on the list that performed very well during 2021 and are expected to do so again in 2022 include Generac Holdings Inc., Bath &amp; Body Works Inc. and General Motors Co..</p><p><b>Midcap stocks expected to show the biggest gains</b></p><p>The lists of &#34;favorite&#34; stocks are confined to those covered by at least five analysts. Among components of the S&amp;P 400 Mid Cap Index, that leaves 92 stocks with at least 75% &#34;buy&#34; ratings. Here at the 20 expected to rise the most over the next year:</p><table><tbody><tr><td>Company</td><td>Ticker</td><td>Industry</td><td>Closing price -- Dec. 30</td><td>Consensus price target</td><td>Implied 12-month upside potential</td><td>Share &#34;buy&#34; ratings</td><td>Total return -- 2021 through Dec. 30</td></tr><tr><td><a href=\"https://laohu8.com/S/RUN\">Sunrun Inc.</a></td><td>RUN</td><td>Alternative Power Generation</td><td>$34.01</td><td>$72.61</td><td>113%</td><td>77%</td><td>-51%</td></tr><tr><td><a href=\"https://laohu8.com/S/APPS\">Digital Turbine Inc.</a></td><td>APPS</td><td>Software</td><td>$62.84</td><td>$104.00</td><td>65%</td><td>100%</td><td>11%</td></tr><tr><td>Jazz Pharmaceuticals Public Ltd. Co.</td><td>JAZZ</td><td>Pharmaceuticals</td><td>$128.26</td><td>$200.89</td><td>57%</td><td>90%</td><td>-22%</td></tr><tr><td>Lithia Motors Inc.</td><td>LAD</td><td>Specialty Stores</td><td>$297.17</td><td>$460.31</td><td>55%</td><td>80%</td><td>2%</td></tr><tr><td><a href=\"https://laohu8.com/S/CRNC\">Cerence Inc.</a></td><td>CRNC</td><td>Software</td><td>$77.59</td><td>$119.42</td><td>54%</td><td>100%</td><td>-23%</td></tr><tr><td>Callaway Golf Co.</td><td>ELY</td><td>Recreational Products</td><td>$27.63</td><td>$41.50</td><td>50%</td><td>77%</td><td>15%</td></tr><tr><td>Ziff Davis Inc.</td><td>ZD</td><td>Internet Software, Services</td><td>$111.37</td><td>$166.88</td><td>50%</td><td>100%</td><td>31%</td></tr><tr><td>Victoria&#39;s Secret &amp; Co.</td><td>VSCO</td><td>Apparel, Footwear Retail</td><td>$55.46</td><td>$82.73</td><td>49%</td><td>82%</td><td>N/A</td></tr><tr><td>LiveRamp Holdings Inc.</td><td>RAMP</td><td>Data Processing Services</td><td>$49.07</td><td>$73.18</td><td>49%</td><td>82%</td><td>-33%</td></tr><tr><td>PROG Holdings Inc.</td><td>PRG</td><td>Finance, Rental, Leasing</td><td>$44.84</td><td>$66.29</td><td>48%</td><td>75%</td><td>-17%</td></tr></tbody></table><table><tbody><tr><td><a href=\"https://laohu8.com/S/MLKN\">MillerKnoll</a> Inc.</td><td>MLKN</td><td>Office Equipment, Supplies</td><td>$38.98</td><td>$57.60</td><td>48%</td><td>80%</td><td>17%</td></tr><tr><td>ChampionX Corp.</td><td>CHX</td><td>Chemicals: Specialty</td><td>$20.01</td><td>$29.00</td><td>45%</td><td>80%</td><td>31%</td></tr><tr><td>Darling Ingredients Inc.</td><td>DAR</td><td>Agricultural Commodities, Milling</td><td>$67.87</td><td>$96.79</td><td>43%</td><td>100%</td><td>18%</td></tr><tr><td>Axon Enterprise Inc.</td><td>AXON</td><td>Aerospace &amp; Defense</td><td>$156.07</td><td>$222.40</td><td>43%</td><td>91%</td><td>27%</td></tr><tr><td>EQT Corp.</td><td>EQT</td><td>Oil &amp; Gas Production</td><td>$22.04</td><td>$31.30</td><td>42%</td><td>75%</td><td>73%</td></tr><tr><td><a href=\"https://laohu8.com/S/IAA\">IAA Inc</a>.</td><td>IAA</td><td>Specialty Stores</td><td>$50.43</td><td>$70.88</td><td>41%</td><td>90%</td><td>-22%</td></tr><tr><td><a href=\"https://laohu8.com/S/HQY\">HealthEquity</a> Inc.</td><td>HQY</td><td>Investment Managers</td><td>$43.86</td><td>$61.50</td><td>40%</td><td>75%</td><td>-37%</td></tr><tr><td><a href=\"https://laohu8.com/S/AZTA\">Azenta</a> Inc.</td><td>AZTA</td><td>Electronic Production Equipment</td><td>$103.18</td><td>$144.60</td><td>40%</td><td>83%</td><td>53%</td></tr><tr><td>Vontier Corp</td><td>VNT</td><td>Transportation</td><td>$30.89</td><td>$42.82</td><td>39%</td><td>77%</td><td>-7%</td></tr><tr><td>SailPoint Technologies Holdings Inc.</td><td>SAIL</td><td>Software</td><td>$48.85</td><td>$67.67</td><td>39%</td><td>93%</td><td>-8%</td></tr><tr><td></td><td>Source: FactSet</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table><p><b>Small-cap favorites for 2022</b></p><p>Among the S&amp;P Small Cap 600, 101 stocks covered by at least five analysts have at least 75% &#34;buy&#34; ratings. Analysts expect these 20 of the favored stocks to rise the most over the next 12 months:</p><table><tbody><tr><td>Company</td><td>Ticker</td><td>Industry</td><td>Closing price -- Dec. 30</td><td>Consensus price target</td><td>Implied 12-month upside potential</td><td>Share &#34;buy&#34; ratings</td><td>Total return -- 2021 through Dec. 30</td></tr><tr><td>UniQure NV</td><td>QURE</td><td>Biotechnology</td><td>$20.87</td><td>$63.78</td><td>206%</td><td>89%</td><td>-42%</td></tr><tr><td><a href=\"https://laohu8.com/S/TCMD\">Tactile Systems Technology Inc</a>.</td><td>TCMD</td><td>Medical Specialties</td><td>$19.23</td><td>$52.25</td><td>172%</td><td>100%</td><td>-57%</td></tr><tr><td>Zynex Inc.</td><td>ZYXI</td><td>Medical Specialties</td><td>$10.23</td><td>$22.20</td><td>117%</td><td>80%</td><td>-24%</td></tr><tr><td>Cara Therapeutics Inc.</td><td>CARA</td><td>Biotechnology</td><td>$12.34</td><td>$26.25</td><td>113%</td><td>75%</td><td>-18%</td></tr><tr><td><a href=\"https://laohu8.com/S/TREE\">LendingTree</a> Inc.</td><td>TREE</td><td>Finance, Rental, Leasing</td><td>$121.91</td><td>$238.75</td><td>96%</td><td>100%</td><td>-55%</td></tr><tr><td>Joint Corp</td><td>JYNT</td><td>Hospital, Nursing Management</td><td>$64.62</td><td>$126.00</td><td>95%</td><td>83%</td><td>146%</td></tr><tr><td>Talos Energy Inc.</td><td>TALO</td><td>Oil &amp; Gas Production</td><td>$10.07</td><td>$19.00</td><td>89%</td><td>100%</td><td>22%</td></tr><tr><td><a href=\"https://laohu8.com/S/REGI\">Renewable Energy Group</a> Inc.</td><td>REGI</td><td>Chemicals</td><td>$42.78</td><td>$79.86</td><td>87%</td><td>80%</td><td>-40%</td></tr><tr><td><a href=\"https://laohu8.com/S/LPSN\">LivePerson</a> Inc.</td><td>LPSN</td><td>Internet Software, Services</td><td>$36.59</td><td>$64.31</td><td>76%</td><td>79%</td><td>-41%</td></tr><tr><td><a href=\"https://laohu8.com/S/BLFS\">BioLife Solutions Inc.</a></td><td>BLFS</td><td>Medical Specialties</td><td>$37.44</td><td>$63.43</td><td>69%</td><td>78%</td><td>-6%</td></tr><tr><td>OptimizeRx Corp.</td><td>OPRX</td><td>Data Processing Services</td><td>$61.14</td><td>$103.00</td><td>68%</td><td>100%</td><td>96%</td></tr><tr><td>Cutera Inc.</td><td>CUTR</td><td>Medical Specialties</td><td>$39.26</td><td>$63.40</td><td>61%</td><td>100%</td><td>63%</td></tr><tr><td><a href=\"https://laohu8.com/S/SEM\">Select Medical Holdings</a> Corp.</td><td>SEM</td><td>Hospital, Nursing Management</td><td>$29.82</td><td>$47.40</td><td>59%</td><td>80%</td><td>9%</td></tr><tr><td>Hibbett Inc.</td><td>HIBB</td><td>Specialty Stores</td><td>$72.00</td><td>$112.17</td><td>56%</td><td>83%</td><td>57%</td></tr><tr><td><a href=\"https://laohu8.com/S/PLMR\">Palomar Holdings</a> Inc.</td><td>PLMR</td><td>Property/ Casualty Insurance</td><td>$63.76</td><td>$99.14</td><td>55%</td><td>78%</td><td>-28%</td></tr><tr><td>Coherus BioSciences Inc.</td><td>CHRS</td><td>Biotechnology</td><td>$16.74</td><td>$25.43</td><td>52%</td><td>86%</td><td>-4%</td></tr><tr><td>Celsius Holdings Inc.</td><td>CELH</td><td>Beverages: Non-Alcoholic</td><td>$73.52</td><td>$110.21</td><td>50%</td><td>75%</td><td>46%</td></tr><tr><td>James River Group Holdings Ltd.</td><td>JRVR</td><td>Property/ Casualty Insurance</td><td>$28.14</td><td>$41.86</td><td>49%</td><td>75%</td><td>-41%</td></tr><tr><td><a href=\"https://laohu8.com/S/NEO\">NeoGenomics</a> Inc.</td><td>NEO</td><td>Medical/ Nursing Services</td><td>$34.15</td><td>$50.18</td><td>47%</td><td>92%</td><td>-37%</td></tr><tr><td>Vericel Corp.</td><td>VCEL</td><td>Medical Specialties</td><td>$40.11</td><td>$58.46</td><td>46%</td><td>100%</td><td>30%</td></tr><tr><td></td><td>Source: FactSet</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table><p><b>All 30 components of the Dow Jones Industrial Average</b></p><p>Here they are, ranked by how much analysts expect them to rise over the next year:</p><table><tbody><tr><td>Company</td><td>Ticker</td><td>Industry</td><td>Closing price -- Dec. 30</td><td>Consensus price target</td><td>Implied 12-month upside potential</td><td>Share &#34;buy&#34; ratings</td><td>Total return -- 2021 through Dec. 30</td></tr><tr><td>Salesforce.com Inc.</td><td>CRM</td><td>Software</td><td>$255.33</td><td>$331.46</td><td>30%</td><td>86%</td><td>15%</td></tr><tr><td>Boeing Co.</td><td>BA</td><td>Aerospace &amp; Defense</td><td>$202.71</td><td>$259.61</td><td>28%</td><td>73%</td><td>-5%</td></tr><tr><td><a href=\"https://laohu8.com/S/V\">Visa</a> Inc. Class A</td><td>V</td><td>Finance, Rental, Leasing</td><td>$217.87</td><td>$272.62</td><td>25%</td><td>92%</td><td>0%</td></tr><tr><td>Walt Disney Co.</td><td>DIS</td><td>Cable, Satellite TV</td><td>$155.93</td><td>$193.29</td><td>24%</td><td>70%</td><td>-14%</td></tr><tr><td>Merck &amp; Co. Inc.</td><td>MRK</td><td>Pharmaceuticals</td><td>$77.14</td><td>$92.70</td><td>20%</td><td>60%</td><td>2%</td></tr><tr><td>Goldman Sachs Group Inc.</td><td>GS</td><td>Investment Banks, Brokers</td><td>$385.52</td><td>$458.97</td><td>19%</td><td>67%</td><td>49%</td></tr><tr><td>Walmart Inc.</td><td>WMT</td><td>Food Retail</td><td>$143.17</td><td>$169.92</td><td>19%</td><td>80%</td><td>1%</td></tr><tr><td>Dow Inc.</td><td>DOW</td><td>Chemicals</td><td>$56.78</td><td>$66.62</td><td>17%</td><td>36%</td><td>7%</td></tr><tr><td>American Express Co.</td><td>AXP</td><td>Finance, Rental, Leasing</td><td>$164.16</td><td>$191.35</td><td>17%</td><td>46%</td><td>37%</td></tr><tr><td>Honeywell International Inc.</td><td>HON</td><td>Industrial Conglomerates</td><td>$207.11</td><td>$238.27</td><td>15%</td><td>48%</td><td>-1%</td></tr></tbody></table><p><table><tbody><tr><td>Caterpillar Inc.</td><td>CAT</td><td>Trucks, Construction, Farm Machinery</td><td>$206.08</td><td>$235.57</td><td>14%</td><td>52%</td><td>16%</td></tr><tr><td>Verizon Communications Inc.</td><td>VZ</td><td>Telecommunications</td><td>$52.25</td><td>$59.57</td><td>14%</td><td>27%</td><td>-7%</td></tr><tr><td>JPMorgan Chase &amp; Co.</td><td>JPM</td><td>Major Banks</td><td>$158.48</td><td>$179.70</td><td>13%</td><td>61%</td><td>28%</td></tr><tr><td>Chevron Corp.</td><td>CVX</td><td>Integrated Oil</td><td>$117.43</td><td>$130.74</td><td>11%</td><td>67%</td><td>46%</td></tr><tr><td>Nike Inc. Class B</td><td>NKE</td><td>Apparel, Footwear</td><td>$167.49</td><td>$185.89</td><td>11%</td><td>77%</td><td>19%</td></tr><tr><td>Microsoft Corp.</td><td>MSFT</td><td>Software</td><td>$339.32</td><td>$370.51</td><td>9%</td><td>90%</td><td>54%</td></tr><tr><td>3M Co.</td><td>MMM</td><td>Industrial Conglomerates</td><td>$177.64</td><td>$192.06</td><td>8%</td><td>14%</td><td>5%</td></tr><tr><td>Coca-Cola Co.</td><td>KO</td><td>Beverages: Non-Alcoholic</td><td>$58.78</td><td>$62.67</td><td>7%</td><td>61%</td><td>11%</td></tr><tr><td>Johnson &amp; Johnson</td><td>JNJ</td><td>Pharmaceuticals</td><td>$172.31</td><td>$183.71</td><td>7%</td><td>50%</td><td>12%</td></tr><tr><td>Intel Corp.</td><td>INTC</td><td>Semiconductors</td><td>$51.74</td><td>$54.91</td><td>6%</td><td>27%</td><td>7%</td></tr><tr><td>International Business Machines Corp.</td><td>IBM</td><td>Information Technology Services</td><td>$133.91</td><td>$142.07</td><td>6%</td><td>28%</td><td>17%</td></tr><tr><td>Amgen Inc.</td><td>AMGN</td><td>Biotechnology</td><td>$226.47</td><td>$238.09</td><td>5%</td><td>31%</td><td>2%</td></tr><tr><td>Travelers Companies Inc.</td><td>TRV</td><td>Multi-Line Insurance</td><td>$156.81</td><td>$164.06</td><td>5%</td><td>26%</td><td>14%</td></tr><tr><td>McDonald’s Corp.</td><td>MCD</td><td>Restaurants</td><td>$267.21</td><td>$276.06</td><td>3%</td><td>70%</td><td>27%</td></tr><tr><td>Home Depot Inc.</td><td>HD</td><td>Home Improvement Chains</td><td>$409.94</td><td>$416.83</td><td>2%</td><td>65%</td><td>58%</td></tr><tr><td>Walgreens Boots Alliance Inc.</td><td>WBA</td><td>Drugstore Chains</td><td>$51.99</td><td>$52.80</td><td>2%</td><td>5%</td><td>35%</td></tr><tr><td>UnitedHealth Group Inc.</td><td>UNH</td><td>Managed Health Care</td><td>$504.43</td><td>$504.20</td><td>0%</td><td>86%</td><td>46%</td></tr><tr><td>Apple Inc.</td><td>AAPL</td><td>Telecommunications Equipment</td><td>$178.20</td><td>$175.81</td><td>-1%</td><td>79%</td><td>35%</td></tr><tr><td>Cisco Systems Inc.</td><td>CSCO</td><td>Information Technology Services</td><td>$63.62</td><td>$62.69</td><td>-1%</td><td>54%</td><td>46%</td></tr><tr><td>Procter &amp; Gamble Co.</td><td>PG</td><td>Household, Personal Care</td><td>$162.77</td><td>$156.67</td><td>-4%</td><td>54%</td><td>20%</td></tr><tr><td>Source: FactSet</td></tr></tbody></table></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PYPL":"PayPal","BK4214":"汽车零售","BK4008":"航空公司","BK4561":"索罗斯持仓","GM":"通用汽车","CZR":"凯撒娱乐","LUV":"西南航空","AAPL":"苹果","LAD":"利西亚车行","BK4500":"航空公司","ALK":"阿拉斯加航空集团有限公司"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2195410116","content_text":"General Motors, Salesforce and PayPal are among the 20 S&P 500 stocks that analysts both heavily favor and expect to rise to the mostWall Street analysts on average expect the stock price of Caesars Entertainment to climb 48% over the next 12 months.As the coronavirus pandemic has stretched out, investors have continued to pour money into stocks, in part because the alternatives have been dismal. Why bother with 10-year U.S. Treasury bonds that yield a paltry 1.52% when the S&P 500 index has a dividend yield of 1.30% to go along with its growth potential?Things may change in 2022 as the Federal Reserve winds down its bond purchases that have kept long-term interest rates low. Then again, U.S. stocks have continued to rise since the Fed announced its policy changes on Dec. 15.With U.S. bond yields already so much higher than they are in the rest of the developed world, foreign investors may continue to buy U.S. bonds and keep yields at historically low levels. And that might make for a continued flow of money into U.S. stocks.Below are lists of stocks among the benchmark S&P 500 , the S&P 400 Mid Cap Index $(MID)$ and the S&P Small Cap 600 Index  that are rated \"buy\" or the equivalent by at least three out of four of Wall Street analysts polled by FactSet that are expected to rise the most over the next year. Those lists are followed by a summary of analysts' opinions of all 30 stocks in the Dow Jones Industrial Average.Large-cap favoritesAmong the S&P 500, 93 stocks are rated a \"buy\" or the equivalent by at least 75% of analysts working for brokerage firms. Here are the 20 the analysts expect to rise the most over the next year, based on consensus price targets:CompanyTickerIndustryClosing price -- Dec. 30Consensus price targetImplied 12-month upside potentialShare \"buy\" ratingsTotal return -- 2021 through Dec. 30Alaska Air Group Inc.ALKAirlines$51.94$77.7150%93%0%Caesars Entertainment Inc.CZRCasinos/ Gaming$92.99$137.3648%94%25%Generac Holdings Inc.GNRCElectrical Products$352.96$514.1146%77%55%PayPal Holdings Inc.PYPLData Processing Services$191.88$273.6543%84%-18%T-Mobile US Inc.TMUSWireless Telecommunications$116.51$165.5142%81%-14%News Corp. Class ANWSAPublishing: Newspapers$22.50$31.9142%88%26%Global Payments Inc.GPNData Processing Services$136.29$188.4138%85%-36%Southwest Airlines Co.LUVAirlines$42.72$57.3234%78%-8%Schlumberger NVSLBOilfield Services/ Equipment$29.82$39.5833%85%39%Salesforce.com Inc.CRMSoftware$255.33$331.4630%86%15%Bath & Body Works Inc.BBWIApparel, Footwear Retail$69.70$90.2129%86%133%Electronic Arts Inc.EARecreational Products$134.46$173.7829%77%-6%Phillips 66PSXOil Refining/ Marketing$72.45$93.5029%79%8%Medtronic PLCMDTMedical Specialties$104.47$134.5229%85%-9%Teleflex Inc.TFXMedical Specialties$330.89$424.1128%75%-19%General Motors Co.GMMotor Vehicles$58.13$74.4528%84%40%Pioneer Natural Resources Co.PXDOil & Gas Production$181.28$231.6128%86%66%Synchrony FinancialSYFFinance, Rental, Leasing$46.26$58.7427%77%36%Comcast Corp. Class ACMCSACable, Satellite TV$50.59$64.0827%79%-2%EOG Resources Inc.EOGOil & Gas Production$89.18$112.9427%79%89%Source: FactSetAlaska Air Group Inc. tops the list of analysts' favorite large-cap stocks for 2022. The shares were flat for 2021, as investors were understandably disappointed that the travel industry's recovery was stalled by new waves of coronavirus infections. Other travel and hospitality-related recovery plays on the list include Caesars Entertainment Inc.  and Southwest Airlines Co..There are four oil-related stocks on the list, three of which rose significantly during 2021. West Texas Crude oil  was up 59% for 2021 through Dec. 30 based on forward-month contracts, while the S&P 500 energy sector returned 54%.Other stocks on the list that performed very well during 2021 and are expected to do so again in 2022 include Generac Holdings Inc., Bath & Body Works Inc. and General Motors Co..Midcap stocks expected to show the biggest gainsThe lists of \"favorite\" stocks are confined to those covered by at least five analysts. Among components of the S&P 400 Mid Cap Index, that leaves 92 stocks with at least 75% \"buy\" ratings. Here at the 20 expected to rise the most over the next year:CompanyTickerIndustryClosing price -- Dec. 30Consensus price targetImplied 12-month upside potentialShare \"buy\" ratingsTotal return -- 2021 through Dec. 30Sunrun Inc.RUNAlternative Power Generation$34.01$72.61113%77%-51%Digital Turbine Inc.APPSSoftware$62.84$104.0065%100%11%Jazz Pharmaceuticals Public Ltd. Co.JAZZPharmaceuticals$128.26$200.8957%90%-22%Lithia Motors Inc.LADSpecialty Stores$297.17$460.3155%80%2%Cerence Inc.CRNCSoftware$77.59$119.4254%100%-23%Callaway Golf Co.ELYRecreational Products$27.63$41.5050%77%15%Ziff Davis Inc.ZDInternet Software, Services$111.37$166.8850%100%31%Victoria's Secret & Co.VSCOApparel, Footwear Retail$55.46$82.7349%82%N/ALiveRamp Holdings Inc.RAMPData Processing Services$49.07$73.1849%82%-33%PROG Holdings Inc.PRGFinance, Rental, Leasing$44.84$66.2948%75%-17%MillerKnoll Inc.MLKNOffice Equipment, Supplies$38.98$57.6048%80%17%ChampionX Corp.CHXChemicals: Specialty$20.01$29.0045%80%31%Darling Ingredients Inc.DARAgricultural Commodities, Milling$67.87$96.7943%100%18%Axon Enterprise Inc.AXONAerospace & Defense$156.07$222.4043%91%27%EQT Corp.EQTOil & Gas Production$22.04$31.3042%75%73%IAA Inc.IAASpecialty Stores$50.43$70.8841%90%-22%HealthEquity Inc.HQYInvestment Managers$43.86$61.5040%75%-37%Azenta Inc.AZTAElectronic Production Equipment$103.18$144.6040%83%53%Vontier CorpVNTTransportation$30.89$42.8239%77%-7%SailPoint Technologies Holdings Inc.SAILSoftware$48.85$67.6739%93%-8%Source: FactSetSmall-cap favorites for 2022Among the S&P Small Cap 600, 101 stocks covered by at least five analysts have at least 75% \"buy\" ratings. Analysts expect these 20 of the favored stocks to rise the most over the next 12 months:CompanyTickerIndustryClosing price -- Dec. 30Consensus price targetImplied 12-month upside potentialShare \"buy\" ratingsTotal return -- 2021 through Dec. 30UniQure NVQUREBiotechnology$20.87$63.78206%89%-42%Tactile Systems Technology Inc.TCMDMedical Specialties$19.23$52.25172%100%-57%Zynex Inc.ZYXIMedical Specialties$10.23$22.20117%80%-24%Cara Therapeutics Inc.CARABiotechnology$12.34$26.25113%75%-18%LendingTree Inc.TREEFinance, Rental, Leasing$121.91$238.7596%100%-55%Joint CorpJYNTHospital, Nursing Management$64.62$126.0095%83%146%Talos Energy Inc.TALOOil & Gas Production$10.07$19.0089%100%22%Renewable Energy Group Inc.REGIChemicals$42.78$79.8687%80%-40%LivePerson Inc.LPSNInternet Software, Services$36.59$64.3176%79%-41%BioLife Solutions Inc.BLFSMedical Specialties$37.44$63.4369%78%-6%OptimizeRx Corp.OPRXData Processing Services$61.14$103.0068%100%96%Cutera Inc.CUTRMedical Specialties$39.26$63.4061%100%63%Select Medical Holdings Corp.SEMHospital, Nursing Management$29.82$47.4059%80%9%Hibbett Inc.HIBBSpecialty Stores$72.00$112.1756%83%57%Palomar Holdings Inc.PLMRProperty/ Casualty Insurance$63.76$99.1455%78%-28%Coherus BioSciences Inc.CHRSBiotechnology$16.74$25.4352%86%-4%Celsius Holdings Inc.CELHBeverages: Non-Alcoholic$73.52$110.2150%75%46%James River Group Holdings Ltd.JRVRProperty/ Casualty Insurance$28.14$41.8649%75%-41%NeoGenomics Inc.NEOMedical/ Nursing Services$34.15$50.1847%92%-37%Vericel Corp.VCELMedical Specialties$40.11$58.4646%100%30%Source: FactSetAll 30 components of the Dow Jones Industrial AverageHere they are, ranked by how much analysts expect them to rise over the next year:CompanyTickerIndustryClosing price -- Dec. 30Consensus price targetImplied 12-month upside potentialShare \"buy\" ratingsTotal return -- 2021 through Dec. 30Salesforce.com Inc.CRMSoftware$255.33$331.4630%86%15%Boeing Co.BAAerospace & Defense$202.71$259.6128%73%-5%Visa Inc. Class AVFinance, Rental, Leasing$217.87$272.6225%92%0%Walt Disney Co.DISCable, Satellite TV$155.93$193.2924%70%-14%Merck & Co. Inc.MRKPharmaceuticals$77.14$92.7020%60%2%Goldman Sachs Group Inc.GSInvestment Banks, Brokers$385.52$458.9719%67%49%Walmart Inc.WMTFood Retail$143.17$169.9219%80%1%Dow Inc.DOWChemicals$56.78$66.6217%36%7%American Express Co.AXPFinance, Rental, Leasing$164.16$191.3517%46%37%Honeywell International Inc.HONIndustrial Conglomerates$207.11$238.2715%48%-1%Caterpillar Inc.CATTrucks, Construction, Farm Machinery$206.08$235.5714%52%16%Verizon Communications Inc.VZTelecommunications$52.25$59.5714%27%-7%JPMorgan Chase & Co.JPMMajor Banks$158.48$179.7013%61%28%Chevron Corp.CVXIntegrated Oil$117.43$130.7411%67%46%Nike Inc. Class BNKEApparel, Footwear$167.49$185.8911%77%19%Microsoft Corp.MSFTSoftware$339.32$370.519%90%54%3M Co.MMMIndustrial Conglomerates$177.64$192.068%14%5%Coca-Cola Co.KOBeverages: Non-Alcoholic$58.78$62.677%61%11%Johnson & JohnsonJNJPharmaceuticals$172.31$183.717%50%12%Intel Corp.INTCSemiconductors$51.74$54.916%27%7%International Business Machines Corp.IBMInformation Technology Services$133.91$142.076%28%17%Amgen Inc.AMGNBiotechnology$226.47$238.095%31%2%Travelers Companies Inc.TRVMulti-Line Insurance$156.81$164.065%26%14%McDonald’s Corp.MCDRestaurants$267.21$276.063%70%27%Home Depot Inc.HDHome Improvement Chains$409.94$416.832%65%58%Walgreens Boots Alliance Inc.WBADrugstore Chains$51.99$52.802%5%35%UnitedHealth Group Inc.UNHManaged Health Care$504.43$504.200%86%46%Apple Inc.AAPLTelecommunications Equipment$178.20$175.81-1%79%35%Cisco Systems Inc.CSCOInformation Technology Services$63.62$62.69-1%54%46%Procter & Gamble Co.PGHousehold, Personal Care$162.77$156.67-4%54%20%Source: FactSet","news_type":1},"isVote":1,"tweetType":1,"viewCount":667,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9042771717,"gmtCreate":1656543500139,"gmtModify":1676535847504,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9042771717","repostId":"9042340268","repostType":1,"repost":{"id":9042340268,"gmtCreate":1656450103554,"gmtModify":1676535828435,"author":{"id":"4119072940563712","authorId":"4119072940563712","name":"TradingLounge","avatar":"https://community-static.tradeup.com/news/e3847b140dde3f0115931dbd158233e5","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4119072940563712","authorIdStr":"4119072940563712"},"themes":[],"title":"NASDAQ, AMZN, AAPL, NVDA, TSLA, GOOGL, BRK.B,SQ,META,MSFT,BAC,JPM. Elliott Wave Stock Market Trading","htmlText":"\n \n \n  NASDAQ, AMZN, AAPL, NVDA, TSLA, GOOGL, BRK, SQ, META, MSFT, BAC, JPM. Elliott Wave Technical Analysis Stock Market TradingElliott Wave Technical Analysis Stocks are in the later stages of the move down (5) of C) of II. That said we are currently in a bear market rally. Covering Tesla TSLA, Amazon AMZN, Nvidia (NVDA), Apple AAPL, Microsoft MSFT, Berkshire Hathaway (BRK/B),Block, Inc (SQ), Facebook FB, Meta Platforms, Alphabet GOOGL. XFL Finance Sector ETF, JPMorgan JPM &amp; Bank of America BAC.Stock Market Summary: Elliott Wave move up as the correctie rally is completed and we are now working then next leg lower.Stock Trading strategies: We are now preparing for short trades on the next corrective rally as the Wave ii)SPECIAL DEAL buy 1 month Get 3 months : tradinglounge.comVideo Chapters\n \n","listText":"NASDAQ, AMZN, AAPL, NVDA, TSLA, GOOGL, BRK, SQ, META, MSFT, BAC, JPM. Elliott Wave Technical Analysis Stock Market TradingElliott Wave Technical Analysis Stocks are in the later stages of the move down (5) of C) of II. That said we are currently in a bear market rally. Covering Tesla TSLA, Amazon AMZN, Nvidia (NVDA), Apple AAPL, Microsoft MSFT, Berkshire Hathaway (BRK/B),Block, Inc (SQ), Facebook FB, Meta Platforms, Alphabet GOOGL. XFL Finance Sector ETF, JPMorgan JPM &amp; Bank of America BAC.Stock Market Summary: Elliott Wave move up as the correctie rally is completed and we are now working then next leg lower.Stock Trading strategies: We are now preparing for short trades on the next corrective rally as the Wave ii)SPECIAL DEAL buy 1 month Get 3 months : tradinglounge.comVideo Chapters","text":"NASDAQ, AMZN, AAPL, NVDA, TSLA, GOOGL, BRK, SQ, META, MSFT, BAC, JPM. Elliott Wave Technical Analysis Stock Market TradingElliott Wave Technical Analysis Stocks are in the later stages of the move down (5) of C) of II. That said we are currently in a bear market rally. Covering Tesla TSLA, Amazon AMZN, Nvidia (NVDA), Apple AAPL, Microsoft MSFT, Berkshire Hathaway (BRK/B),Block, Inc (SQ), Facebook FB, Meta Platforms, Alphabet GOOGL. XFL Finance Sector ETF, JPMorgan JPM & Bank of America BAC.Stock Market Summary: Elliott Wave move up as the correctie rally is completed and we are now working then next leg lower.Stock Trading strategies: We are now preparing for short trades on the next corrective rally as the Wave ii)SPECIAL DEAL buy 1 month Get 3 months : tradinglounge.comVideo Chapters","images":[{"img":"https://community-static.tradeup.com/news/9430a9b23ab49bd3c719810b1eab9493","width":"0","height":"0"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9042340268","isVote":1,"tweetType":2,"object":{"id":"85a868088e76492d9890af2d2fd36e98","tweetId":"9042340268","videoUrl":"https://1254107296.vod2.myqcloud.com/8e2bc32evodtranshk1254107296/6bddd4a1387702302338810122/v.f30.mp4","poster":"https://community-static.tradeup.com/news/9430a9b23ab49bd3c719810b1eab9493"},"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":438,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006299673,"gmtCreate":1641742627231,"gmtModify":1676533644113,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"Thx","listText":"Thx","text":"Thx","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006299673","repostId":"2201249471","repostType":4,"repost":{"id":"2201249471","kind":"highlight","pubTimestamp":1641691426,"share":"https://ttm.financial/m/news/2201249471?lang=&edition=fundamental","pubTime":"2022-01-09 09:23","market":"us","language":"en","title":"My 3 Favorite Stocks Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2201249471","media":"Motley Fool","summary":"These glaring deals from the small and mid-cap arena could be substantial long-term winners.","content":"<html><head></head><body><p>Unless a portfolio is constructed entirely of mega-cap stocks, it&#39;s probably seeing more red than green days lately. The market can seem like a popularity contest, and small and mid-cap growth stocks are not cool right now.</p><p>But it would help if investors looked at the positives in all of this selling pressure. With so many stocks selling off, it&#39;s a great time to buy stocks at great prices. The market has hammered these three stocks recently, but they have a long-term upside that could make them huge winners down the road.</p><h2>1. Affirm Holdings</h2><p>Buy now, pay later (BNPL) took 2021 by storm, growing roughly fourfold to $100 billion this past year. Experts think it could expand to 15 times its current volume by 2025. The simple structure of fixed installments that often carry zero interest is rapidly gaining popularity over traditional consumer credit cards.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/60125fdb7af8793177def84d6bf63e34\" tg-width=\"700\" tg-height=\"444\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><p><b>Affirm</b> (NASDAQ:AFRM) is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading BNPL companies. It works with its retail partners to offer installment payment plans on products. Users can shop right from the Affirm app and use Affirm&#39;s payment tools when checking out. Retailers have an incentive to use BNPL because it increases order size and customer loyalty. Shoppers can fit more into their carts, and they like the simple financing. In other words, it has become a sales tool for retailers.</p><p>Affirm has secured numerous partnerships with leading e-commerce merchants, including <b>Amazon</b>, <b>Walmart</b>, <b>Shopify</b>, and <b>Target</b>. In its first quarter of 2022 (period ending Sept. 30, 2021), the company reported that its merchant partnerships had increased 1,468% year over year to 102,200. Affirm hasn&#39;t even commented on its guidance since announcing the Amazon partnership, so it seems reasonable that its 84% year-over-year merchandise volume growth in 2022 Q1 could continue from here.</p><p>Despite this good news, the stock has been caught up in a broader market tech sell-off and has fallen more than 50% from its highs. At $80 per share, the stock almost trades as low as before Affirm announced the Amazon partnership.</p><p>Affirm isn&#39;t profitable, but it&#39;s spending heavily on building new products and services; it has ambitions of becoming a broader financial services company, bringing a finance super-app and debit card to market over the coming quarters. As these products launch and revenue grows, investors should look for the business to begin heading toward a positive operating income.</p><h2>2. Crowdstrike Holdings</h2><p>The world is becoming increasingly digital at a rapid pace. Yet, consumers&#39; and businesses&#39; tools to protect themselves from digital threats are largely still behind the times. Someone could do a simple internet search and find countless instances of breached, hacked, or compromised companies.</p><p><b>CrowdStrike</b> (NASDAQ:CRWD) is a cloud-based leader in endpoint security, in which a network protects user devices like computers and mobile devices from digital threats. In the old days, people would download antivirus software, receive occasional updates from the security company which ultimately would tell the antivirus program what threats looked like.</p><p>CrowdStrike&#39;s Falcon platform delivers various protections through the cloud, giving the software real-time information and updates. Devices connected on Falcon are linked, similar to a massive network. If an attack happens on one device, the system learns and instantly shares this information with the other devices throughout the network. As more devices are connected, it creates a network effect, and the Falcon platform learns more, faster.</p><p>The stock has had a great run since COVID-19 started but has since pulled back roughly 40% from its highs. CrowdStrike grew subscription revenue 67% year over year in its most recent quarter, the third quarter of 2022 (Oct. 31, 2021), to $357 million. The company is reporting net losses but is growing its free cash flow; it was $123.5 million in 2022 Q3, a 62% year-over-year increase. Free cash flow is a positive step toward posting a profit, so investors should look for cash flow to keep growing, and net losses to shrink over the coming quarters.</p><h2>3. Sea Limited</h2><p>The population in Southeast Asia is friendly toward technology; the region boasts a population of roughly 670 million, and half are under age 30. They also tend to spend eight hours on the internet each day, more than the global average. In other words, they are a great target market for digital businesses.</p><p><b>Sea Limited</b> (NYSE:SE) is an internet company with various digital business segments, including e-commerce, mobile gaming, and financial services. Garena, its gaming business, is driven by FreeFire, one of the most popular mobile games in the world. It&#39;s also the most profitable part of the company, responsible for all of Sea&#39;s adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA).</p><p>The company uses these profits to expand other parts of its business heavily. For example, Sea has taken its e-commerce business, Shopee, to other regions in the world, including Latin America, Europe, and India. The company is aggressively pumping its cash back into the business to pay for the employees, buildings, and resources needed for these new markets, so the overall business is losing money right now. However, I expect that the spending eventually levels off, and revenue growth will outpace the money Sea spends, pushing the company toward profits. Investors will want to pay attention to whether losses grow or shrink in future quarters.</p><p>Sea&#39;s total revenue grew 122% year over year in its most recent quarter, 2021 Q3, and there is reason to believe that rapid growth can continue for years to come. E-commerce, gaming, and fintech are all massive addressable markets, and Sea&#39;s ambition to attack them at a global scale gives the business a virtually endless runway for growth. The stock is 50% off its highs, so investors with the patience to hold for the long term could be scooping up shares at a nice discount.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>My 3 Favorite Stocks Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMy 3 Favorite Stocks Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-09 09:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/08/my-3-favorite-stocks-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Unless a portfolio is constructed entirely of mega-cap stocks, it's probably seeing more red than green days lately. The market can seem like a popularity contest, and small and mid-cap growth stocks ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/08/my-3-favorite-stocks-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4551":"寇图资本持仓","BK4535":"淡马锡持仓","BK4566":"资本集团","BK4548":"巴美列捷福持仓","BK4106":"数据处理与外包服务","BK4097":"系统软件","SE":"Sea Ltd","BK4554":"元宇宙及AR概念","BK4560":"网络安全概念","BK4085":"互动家庭娱乐","BK4528":"SaaS概念","CRWD":"CrowdStrike Holdings, Inc.","BK4503":"景林资产持仓","BK4532":"文艺复兴科技持仓","AFRM":"Affirm Holdings, Inc."},"source_url":"https://www.fool.com/investing/2022/01/08/my-3-favorite-stocks-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2201249471","content_text":"Unless a portfolio is constructed entirely of mega-cap stocks, it's probably seeing more red than green days lately. The market can seem like a popularity contest, and small and mid-cap growth stocks are not cool right now.But it would help if investors looked at the positives in all of this selling pressure. With so many stocks selling off, it's a great time to buy stocks at great prices. The market has hammered these three stocks recently, but they have a long-term upside that could make them huge winners down the road.1. Affirm HoldingsBuy now, pay later (BNPL) took 2021 by storm, growing roughly fourfold to $100 billion this past year. Experts think it could expand to 15 times its current volume by 2025. The simple structure of fixed installments that often carry zero interest is rapidly gaining popularity over traditional consumer credit cards.Image source: Getty Images.Affirm (NASDAQ:AFRM) is one of the leading BNPL companies. It works with its retail partners to offer installment payment plans on products. Users can shop right from the Affirm app and use Affirm's payment tools when checking out. Retailers have an incentive to use BNPL because it increases order size and customer loyalty. Shoppers can fit more into their carts, and they like the simple financing. In other words, it has become a sales tool for retailers.Affirm has secured numerous partnerships with leading e-commerce merchants, including Amazon, Walmart, Shopify, and Target. In its first quarter of 2022 (period ending Sept. 30, 2021), the company reported that its merchant partnerships had increased 1,468% year over year to 102,200. Affirm hasn't even commented on its guidance since announcing the Amazon partnership, so it seems reasonable that its 84% year-over-year merchandise volume growth in 2022 Q1 could continue from here.Despite this good news, the stock has been caught up in a broader market tech sell-off and has fallen more than 50% from its highs. At $80 per share, the stock almost trades as low as before Affirm announced the Amazon partnership.Affirm isn't profitable, but it's spending heavily on building new products and services; it has ambitions of becoming a broader financial services company, bringing a finance super-app and debit card to market over the coming quarters. As these products launch and revenue grows, investors should look for the business to begin heading toward a positive operating income.2. Crowdstrike HoldingsThe world is becoming increasingly digital at a rapid pace. Yet, consumers' and businesses' tools to protect themselves from digital threats are largely still behind the times. Someone could do a simple internet search and find countless instances of breached, hacked, or compromised companies.CrowdStrike (NASDAQ:CRWD) is a cloud-based leader in endpoint security, in which a network protects user devices like computers and mobile devices from digital threats. In the old days, people would download antivirus software, receive occasional updates from the security company which ultimately would tell the antivirus program what threats looked like.CrowdStrike's Falcon platform delivers various protections through the cloud, giving the software real-time information and updates. Devices connected on Falcon are linked, similar to a massive network. If an attack happens on one device, the system learns and instantly shares this information with the other devices throughout the network. As more devices are connected, it creates a network effect, and the Falcon platform learns more, faster.The stock has had a great run since COVID-19 started but has since pulled back roughly 40% from its highs. CrowdStrike grew subscription revenue 67% year over year in its most recent quarter, the third quarter of 2022 (Oct. 31, 2021), to $357 million. The company is reporting net losses but is growing its free cash flow; it was $123.5 million in 2022 Q3, a 62% year-over-year increase. Free cash flow is a positive step toward posting a profit, so investors should look for cash flow to keep growing, and net losses to shrink over the coming quarters.3. Sea LimitedThe population in Southeast Asia is friendly toward technology; the region boasts a population of roughly 670 million, and half are under age 30. They also tend to spend eight hours on the internet each day, more than the global average. In other words, they are a great target market for digital businesses.Sea Limited (NYSE:SE) is an internet company with various digital business segments, including e-commerce, mobile gaming, and financial services. Garena, its gaming business, is driven by FreeFire, one of the most popular mobile games in the world. It's also the most profitable part of the company, responsible for all of Sea's adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA).The company uses these profits to expand other parts of its business heavily. For example, Sea has taken its e-commerce business, Shopee, to other regions in the world, including Latin America, Europe, and India. The company is aggressively pumping its cash back into the business to pay for the employees, buildings, and resources needed for these new markets, so the overall business is losing money right now. However, I expect that the spending eventually levels off, and revenue growth will outpace the money Sea spends, pushing the company toward profits. Investors will want to pay attention to whether losses grow or shrink in future quarters.Sea's total revenue grew 122% year over year in its most recent quarter, 2021 Q3, and there is reason to believe that rapid growth can continue for years to come. E-commerce, gaming, and fintech are all massive addressable markets, and Sea's ambition to attack them at a global scale gives the business a virtually endless runway for growth. The stock is 50% off its highs, so investors with the patience to hold for the long term could be scooping up shares at a nice discount.","news_type":1},"isVote":1,"tweetType":1,"viewCount":818,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9031523658,"gmtCreate":1646618158403,"gmtModify":1676534143995,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"Thx","listText":"Thx","text":"Thx","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031523658","repostId":"2217949664","repostType":2,"isVote":1,"tweetType":1,"viewCount":562,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9079918287,"gmtCreate":1657145782749,"gmtModify":1676535955688,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9079918287","repostId":"9070284014","repostType":1,"repost":{"id":9070284014,"gmtCreate":1657067477439,"gmtModify":1676535942615,"author":{"id":"4119072940563712","authorId":"4119072940563712","name":"TradingLounge","avatar":"https://community-static.tradeup.com/news/e3847b140dde3f0115931dbd158233e5","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4119072940563712","authorIdStr":"4119072940563712"},"themes":[],"title":"ASX200, CBA, Iron Ore, BHP, FMG, RIO, GOLD, NCM, Natural Gas, Crude Oil AUDUSD DXY Elliott Wave","htmlText":"\n \n \n  Australian Stock Market Elliott Wave Analysis Trading Levels ASX 200 Index (XJO), Forex AUDUSD, Commonwealth Bank CBA, BHP Group (BHP), Rio Tinto (RIO), Fortescue Metals Group (FMG), Woodside (WDS) Santos (STO), Newcrest Mining NCM, VanEck Gold Miners ETF GDX, Technical Analysis Trading StrategiesASX200 Market Summary Elliott Wave ASX200: Wave (4) completed and the next leg lower is underway...as one's and two'sASX200 Trading Strategy: In this video we are looking for short trade setups in the ASX200 as Wave v of (c) of ii)Video Chapters 00:00 ASX200 (XJO) 07:10 Commonwealth Bank CBA 08:17 Iron Ore BHP RIO FMG 13:39 Natural Gas, STO, WDS 20:12 US Spot Gold GDX NCM 26:32 Thanks for watching! &nbsp;Analyst Peter Mathers TradingLounge™ Australian Financial Services Licence - AFSL 317817@Daily\n \n","listText":"Australian Stock Market Elliott Wave Analysis Trading Levels ASX 200 Index (XJO), Forex AUDUSD, Commonwealth Bank CBA, BHP Group (BHP), Rio Tinto (RIO), Fortescue Metals Group (FMG), Woodside (WDS) Santos (STO), Newcrest Mining NCM, VanEck Gold Miners ETF GDX, Technical Analysis Trading StrategiesASX200 Market Summary Elliott Wave ASX200: Wave (4) completed and the next leg lower is underway...as one's and two'sASX200 Trading Strategy: In this video we are looking for short trade setups in the ASX200 as Wave v of (c) of ii)Video Chapters 00:00 ASX200 (XJO) 07:10 Commonwealth Bank CBA 08:17 Iron Ore BHP RIO FMG 13:39 Natural Gas, STO, WDS 20:12 US Spot Gold GDX NCM 26:32 Thanks for watching! &nbsp;Analyst Peter Mathers TradingLounge™ Australian Financial Services Licence - AFSL 317817@Daily","text":"Australian Stock Market Elliott Wave Analysis Trading Levels ASX 200 Index (XJO), Forex AUDUSD, Commonwealth Bank CBA, BHP Group (BHP), Rio Tinto (RIO), Fortescue Metals Group (FMG), Woodside (WDS) Santos (STO), Newcrest Mining NCM, VanEck Gold Miners ETF GDX, Technical Analysis Trading StrategiesASX200 Market Summary Elliott Wave ASX200: Wave (4) completed and the next leg lower is underway...as one's and two'sASX200 Trading Strategy: In this video we are looking for short trade setups in the ASX200 as Wave v of (c) of ii)Video Chapters 00:00 ASX200 (XJO) 07:10 Commonwealth Bank CBA 08:17 Iron Ore BHP RIO FMG 13:39 Natural Gas, STO, WDS 20:12 US Spot Gold GDX NCM 26:32 Thanks for watching! Analyst Peter Mathers TradingLounge™ Australian Financial Services Licence - AFSL 317817@Daily","images":[],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9070284014","isVote":1,"tweetType":2,"object":{"id":"098d58bf19cc46cc9db1d2bd86ef020e","tweetId":"9070284014","videoUrl":"https://1254107296.vod2.myqcloud.com/3e467bc5vodtranssgp1254107296/09e5ac4c387702302931753074/v.f30.mp4","poster":"https://community-static.tradeup.com/news/034ed2fa8717605bb091dbd1c5ebb866"},"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":427,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002553232,"gmtCreate":1642047446311,"gmtModify":1676533675805,"author":{"id":"3571797176941843","authorId":"3571797176941843","name":"RP0738","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571797176941843","authorIdStr":"3571797176941843"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002553232","repostId":"2202730280","repostType":4,"isVote":1,"tweetType":1,"viewCount":768,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}